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1. Abbreviations 
AC:   adenylate cyclase 
ADM:    adrenomedullin 
AMP:   adenosine monophosphate 
ATP:   adenosine triphosphate 
Ca2+:   calcium, ionic calcium 
[Ca2+]i:   intracellular calcium concentration 
[Ca2+]e:   extracellular calcium concentration 
CALC:   calcitonin (genes) 
cAMP:   cyclic adenosine monophosphate 
CASR:   calcium-sensing receptor 
CCP-I:    calcitonin carboxypeptide-I, katacalcin 
CGRP:    calcitonin gene related peptide 
CRE:   cAMP-response element 
CREB:   CRE binding protein 
CREM:   CRE modulator 
CRP:   C-reactive protein 
CT:    calcitonin 
DRE:   downstream regulatory element 
DREAM:  downstream regulatory element antagonist modulator 
IL-1:    interleukin-1  
IL-6:    interleukin-6 
IL-8:   interleukin-8 
INF:   interferon 
IP3:   inositol-1,4,5-trisphosphate  
IP3R:   inositol-1,4,5-trisphosphate receptor 
LPS:    lipopolysaccharide 
MCP 1:   monocyte chemoattractant protein 1 
MMCP:  mitochondrial membrane calcium pump 
MNCX:  mitochondrial sodium/calcium exchanger 
MPT:   mitochondrial permeability transition 
MR-ProADM:  midregional fragment of pro-adrenomedullin  
MSC:    mesenchymal stem cells 
MTC:   medullary thyroid carcinoma 
MyD88:  Myeloid differentiation primary response gene (88) 
NCX:   sodium/calcium exchanger 
NFκB:   nuclear factor kappa B 
N-ProCT:   aminoprocalcitonin 
PAM:   peptidylglycine-amidating monooxygenase  
PAMP:   pathogen-associated molecular patterns 
PK:   protein kinase 
PMCA:   plasma membrane calcium pump 
ProADM:  proadrenomedullin 
ProCT:   procalcitonin 
PTH:   parathyroid hormone 
RyR:   ryanodine receptor 
SERCA :  sarco-endoplasmic reticulum Ca2+ ATPase 
SIRS:    systemic inflammatory response syndrome 
SVF:   stromal vascular cell fraction 
TIR:   Toll/interleulin-1-receptor    
TIRAP:   (TIR)-domain-containing-adaptor protein 
TLR:   toll-like receptor 
TNF-α:   tumor necrosis factor alpha 
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2. Summary 
Systemic bacterial infections induce an ubiquitous expression of calcitonin (CALC) 
genes with sustained release of calcitonin (CT) peptides, namely procalcitonin 
(ProCT), calcitonin-gene related peptide (CGRP) and adrenomedullin (ADM). ProCT 
is a marker to follow the course of sepsis and to guide antibiotic therapy and a dose-
dependent toxic mediator. Persistently and markedly elevated levels of ProCT and 
even more of ProADM during bacterial infection and sepsis indicate a bad prognosis. 
The molecular mechanisms as to how extrathyroidal CALC gene expression and 
protein secretion is regulated in sepsis are unknown.  
Since the neuro-endocrine CT expression in the parafollicular C-cells of the thyroid is 
calcium dependent, we hypothesized that calcium might also be involved in the non-
neuro-endocrine expression and secretion of CT peptides. We therefore monitored 
preadipocyte-derived adipocytes for changes in intracellular calcium concentrations 
upon treatment with lipopolysaccharide (LPS) with confocal microscopy. LPS-
stimulated cells were treated with substances which provoke or block an increase in 
intracellular calcium concentrations or increase levels of cAMP and changes in 
CALC-I gene (i.e. CT and CGRP-I) and CALC-V gene (i.e. ADM) mRNA expression 
were assessed by real-time PCR. Protein secretions in supernatants were measured by 
specific assays. In addition to the CALC genes, changes of IL-6 mRNA and protein 
were measured.  
Administration of LPS on human adipocytes led to a slow and sustained increase in 
the intracellular calcium concentration without apparent cytotoxic effect on the cells. 
LPS-induced CALC-I mRNA expression was potentiated with increasing intracellular 
calcium concentrations
 
through addition of the calcium ionophore ionomycin or 
depletion of intracellular stores with thapsigargin. When diminishing intracellular 
calcium concentrations in LPS-treated adipocytes
 
by verapamil or 2-
aminoethoxydiphenyl borate, the CALC-I gene expression was reduced. This was 
confirmed at the protein level for ProCT and CGRP-I.  
Interestingly, we observed an inverse effect of intracellular calcium on the expression 
of the CALC-I and the CALC-V gene. Elevations of intracellular calcium in an 
inflammatory background caused by LPS potentiated the activity of the CALC-I 
genes CT and CGRP-I but reduced the expression of the CALC-V gene ADM, both at 
the mRNA and the protein level.  IL-6 mRNA expression levels was also altered upon 
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increased and decreased levels of intracellular calcium concentrations, but to a much 
lower extend as compared to that of the CALC-I gene. LPS-induced expression of CT 
and CGRP-I mRNA was independent from nuclear factor kappa B (NFκB), in contrast 
to IL-6-expression. 
In conclusion, the expression of CT and CGRP-I in human preadipocyte-derived 
adipocytes upon stimulation with LPS is mediated by changes in intracellular calcium 
concentrations and by cAMP and is independent of NFκB. The distinct and inverse 
effect of calcium on CALC-I and CALC-V gene expression might at least in part 
explain the different clinical characteristics of ProCT as diagnostic and ProADM as 
prognostic marker. 
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3. Introduction 
3.1 The Calcitonin Gene Family 
The calcitonin (CALC) gene family of peptides consists of calcitonin (CT), calcitonin 
gene related peptides-I and -II (CGRP-I, CGRP-II), amylin (AMY) and 
adrenomedullin (ADM). These calcitonin peptides (CT peptides) are translated from 
the CALC genes CALC-I, CALC-II, CALC-IV and CALC-V (Fig. 1), which were 
derived from gene duplication during evolution. The CALC III gene is a non-
transcribed pseudo gene. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: CALC genes and the CT peptides. CALC-I gene products include CT, its 
precursor peptide ProCT and through alternative splicing CGRP-I. CALC-II gene encodes 
CGRP-II. ProCT and CT can not be expressed from the CALC-II gene due to a stop codon in 
exon 4. CALC-III (not shown) is a non-translated pseudogene. CALC-IV encodes the peptide 
amylin. CALC-V gene encodes ADM (adapted from Becker et al. 2001 (1)). 
 
Human CT, CGRP-I, CGRP-II, amylin and ADM have in common a N terminal 6-7 
amino acid ring structure, required for biological activity (2), and amidated C-termini 
(Fig. 2). Additional amino acids in the middle and C-terminal regions are identical in 
several peptides. Unique among this family of peptides, human ADM has a linear N-
terminal extension of the ring structure of 15 amino acids (3). 
 
IV VIVIIII II
IV VIVIIII II
STOP
IV VIVIIII II
VI II
CALC-I
CALC-II
CALC-IV
CALC-V
IVI II
IV
VIV
VIV
V
IVI II
ProCT
CT
CGRP-I
CGRP-II
Amylin
ADM
alternative 
mRNA-splicing
GENES PEPTIDES
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Figure 2: Amino acid sequences of human CT, CGRP-I and –II, ADM and amylin 
(adapted from Muff et.al 1995 (3)) 
 
The CT peptides are classified as peptide hormones with neuro-endocrine functions. 
Like other proteins, peptide hormones are synthesized as pre-prohormones and then 
processed in several stages into prohormones. The prohormones are then packed into 
membrane-bound secretory vesicles which are secreted by exocytosis in response to 
specific stimuli, such as increased serum calcium concentrations (4). The so-called 
prohormones of the mature hormones CT and ADM, namely ProCT and ProADM, 
emerged as biomarkers and mediators for bacterial infection, antibiotic guidance, 
estimation of disease prognosis and target for immunoneutralisation and antimicrobial 
drugs in sepsis (5-8). 
3.1.1 The CALC-I gene product 
Alternative splicing of the initial gene transcripts in a tissue specific manner results in 
the production of two distinct messenger RNA (mRNA) encoding precursors of CT 
and of CGRP-I.  
3.1.1.1 CT 
The 32-amino acid hormone CT was the first regulatory peptide discovered from the 
CALC gene family by Copp et al. in 1962 (9). It is synthesized in the parafollicular 
“clear” cells or “C-cells” of the thyroid gland, the endocrine “K cells” of the lung, and 
possibly in the brain and pituitary. CT is secreted in response to induced 
hypercalcemia (9-11). It is thought to be involved in protecting the skeleton during 
periods of "calcium stress" such as growth, pregnancy, and lactation. In clinics, it is 
used as a specific marker to identify medullary carcinoma of the thyroid (MCT) and 
as follow-up measure during its treatment (12).  
__________   
I             I  
C G N L S T C M L G T Y T Q D F N K F H T - - - - - F P Q T A  I G V G A - P-NH2 CT
I  I                                                        I         I         I          I
A C D T A T C V T H R L A G L L S R S G G V V K N N F V P T N V G S K A - F-NH2 CGRP-I
I  I      I  I   I  I   I  I  I   I  I  I   I   I  I  I  I   I  I   I  I   I I  I   I  I   I  I   I  I  I   I   I  I  I     I
A C N T A T C V T H R L A G L L S R S G G V V K N N F V P T N V G S K A - F-NH2 CGRP-II
I         I  I                I   I                                   I     I          I                I
Y R Q S M N N F Q G L R S F G C R F G T C T V Q K L A H Q I Y Q F T D K D K D N V A P R S K  I S P Q G Y-NH2  ADM
I             I   I         I      I                            I              I
K C N T A T C A T Q R L A N F L V H S S N N F G A I L S S T N V G S N T      Y-NH2 AMYLIN
I________I
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Thyroid C-cells contain secretory granules which are stored as a pre-made pool of 
stable granules. Like most peptide hormones, mature CT is initially biosynthesized as 
a large molecular weight precursor hormone, i.e. preprocalcitonin, which then is 
subsequently processed into smaller peptides, including CT, ProCT, free calcitonin 
carboxypeptide-I (CCP-I), conjoined CT:CCP-I and  free aminoprocalcitonin (N-
ProCT)  (Figure 3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Schematic diagram of the human calcitonin precursors. Mainly in thyroidal C-
cells, immature calcitonin is amidated into mature calcitonin by the enzyme peptidylglycine-
amidating monooxygenase (PAM). CCP-I = calcitonin carboxypeptide-I (Müller et al. 2000 
(13)). 
 
All of these component peptides are found in the sera of healthy persons (14). 
3.1.1.2 CGRP-I 
CGRP-I was identified in 1981 by Rosenfeld et al. (15) as an alternative splicing 
variant of the CALC-I gene. CGRP-I mRNA is the predominant transcription product 
of the CALC-I gene in neural tissues, but it is also present in the pituitary and C-cells 
of normal thyroid glands and in medullary thyroid carcinoma. CGRP-I is released 
from nerve terminals by voltage-dependent calcium uptake, among other mechanisms. 
PREPROCALCITONIN
PROCALCITONIN
AMINOPROCALCITONIN CALCITONIN : CCP-I
IMMATURE CALCITONIN CCP-I (Katacalcin)
CALCITONIN
COOHNH2
(PAM)
LEADER 
SEQUENCE
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As a result, CGRP-I acts mainly locally without reaching the general circulation. It is 
the most potent vasodilator known so far. ProCGRP and ProCT share an identical 
aminoterminal precursor fragment. Nothing is known on the bioactivity of its 
carboxy-terminal precursor peptides. 
3.1.2 The CALC-II gene product 
No preproCT-II mRNA is detected due to a mutated STOP codon in exon IV. The 
CALC-II gene is transcribed to preproCGRP-II mRNA and translated into CGRP-II 
protein and its precursor peptides. Mature CGRP-I and-II only differ in three from 37 
amino acids. CGRP-II is a less potent vasodilator but a more potent inhibitor of 
gastric acid as compared to CGRP-I (16). 
3.1.3 The CALC-IV gene product 
The peptide Amylin is generated from the CALC-IV gene and shares over 40% amino 
acid sequence homology with CGRP and 20% with human CT. Amylin is 
predominantly located in the beta cells of the islets of the pancreas and is co-secreted 
with insulin. It is involved in the pathogenesis of type II diabetes by deposition as 
amyloid within the pancreas, leading to “amyloidosis” and beta cell destruction (17), 
hence its initial name as “islet amyloid polypeptide” (IAPP). 
3.1.4 The CALC-V gene product 
The vasoactive peptide ADM was discovered in 1993 in the adrenal medulla and is 
translated from the CALC-V gene. It shares 24% homology with CGRP and also has a 
biological activity profile similar to that of CGRP. Together with CGRP ADM 
belongs to the most potent vasodilators known so far (18). Due to its high expression 
in endothelial cells it has come to be regarded as a secretory product of the vascular 
endothelium. The ADM gene is expressed in a wide range of tissues and has 
additional immune modulating, metabolic properties. ADM also has bactericidal 
activity, which is further enhanced by modulation of complement activity and 
regulation (19, 20). 
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3.2 CT peptides and sepsis  
3.2.1 Sepsis 
Sepsis is a major challenge in the intensive care unit, where it’s one of the leading 
causes of death. It arises unpredictably and can progress rapidly (21, 22). Sepsis is the 
systemic response to the infection and is manifested by two or more of the following 
criteria of the systemic inflammatory response syndrome (SIRS), which is a clinical 
expression of nonspecific inflammation. SIRS is characterized by varying 
combinations of fever or hypothermia, tachypnea, tachycardia, and 
polymorphonucleocytosis or leucopenia. The infection causing sepsis can origin 
anywhere in the body. Many different types of microbes such as bacteria, fungi and 
viruses can cause sepsis, but bacteria are the most common initiators. In sepsis, the 
patient is harmed because of the initial injury or infection but also because of the 
humoral and / or cellular overreaction of the host. This triggers a widespread 
inflammation, which leads to blood clots and leaky vessels and organ dysfunctions. 
An impaired blood flow damages metabolically activated inflamed organs by 
depriving them of nutrients and oxygen. In severe cases, one or more organs fail. 
Ultimately, blood pressure drops and the patient dies from multiorgan failure. 
3.2.2 The hormokine concept 
Hormones are produced by endocrine and neuro-endocrine cells and are secreted into 
the circulatory system from where they are disseminated throughout the body in order 
to regulate the function of peripheral tissues and, thus, maintaining feedback-
regulated homeostasis. Cytokines are produced by multiple cell types of different 
embryonic origin and mediate mainly local and immunomodulating effects. 
Importantly upon systemic infection and inflammatory stimulation, allegedly 
hormonal CALC genes become transcribed and translated. As a result, hormonal 
precursor peptides of the CALC genes are ubiquitously released by non-endocrine, 
parenchymal cells throughout the body in a cytokine-like behavior. To encompass this 
plasticity of hormones, the term “hormokine” was coined. The concept was based on 
the finding of a ubiquitous expression of the CT peptides during sepsis in a hamster 
model (23, 24), subsequently verified for pigs (25, 26) and primates (26), including 
humans (27, 28) . The ubiquitous inflammatory release is induced either directly, via 
microbial toxins such as the endotoxin lipopolysaccharide (LPS), or indirectly, by 
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mediators of the humoral or cell mediated host response (e.g. interleukin (IL)-1β, 
tumour necrosis factor (TNF) - α and IL-6) (28). Parenchymal cells such as liver, 
kidney, muscle cells and adipocytes provide the largest tissue mass in the body and 
the principle source of circulating hormokines in sepsis. The induction in mRNA and 
the release of peptides from parenchymal cells is much greater compared to that of 
circulating blood cells in sepsis, where only a transient release can be found (29). This 
indicates for hormonkines a tissue based rather than leukocyte based form of host 
defense. As such, hormokines are thought to adapt metabolism and vascular tone to 
acute needs in inflammation and to combat invading microbes during exogenous 
infections. 
3.2.3 Increased levels of CT precursor peptides in bacterial infection and sepsis 
In the healthy state, circulating levels of CT precursors, including ProCT, are very 
low (< 0.05 ng/ml). In patients with severe inflammation and especially in systemic 
bacterial infection (“sepsis”) up to septic shock circulating levels of several CT 
precursor peptides increase to levels up to 1000 ng/ml. This increase correlates with 
the severity of the illness and with mortality (30). Within 2-3 hours after induction of 
an infection (e.g. by endotoxin), ProCT levels increase, rising rapidly to reach a 
plateau within 6-12 hours. ProCT concentrations remain high for up to 48 hours and 
then, upon resolution of the infection, fall back to their baseline values with a half-life 
of 20 to 24 hours (30, 31).  
ProCT has a superior diagnostic accuracy for the diagnosis of sepsis as compared to 
other markers of inflammation (e.g. IL-6), C-reactive protein (CRP) or lactate (6, 30, 
32, 33) (Figure 5). Presently a variety of biomarkers with distinct diagnostic spectrum 
for sepsis is available. Some markers primarily indicate the severity of inflammation 
(e.g. IL-6), others respond to infection, but do not indicate the host response well 
(endotoxin, lipoprotein binding protein, triggering receptor on myeloid cells). In 
comparison, ProCT is a well-established biomarker of sepsis that fulfills several 
criteria of clinical needs: it responds both to infection and to the severity of 
inflammation and thus has an impact on therapy. Highly sensitive ProCT 
measurements, embedded in diagnosis-specific clinical algorithms, have been shown 
to markedly reduce the overuse of antibiotic therapy without increasing risk to 
patients in 11 randomized controlled trials including over 3500 patients from different 
European countries (34). 
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Figure 5: ProCT versus CRP, IL-6 and Lactate. The receiver-operating characteristics of 
the daily values of several markers for the severity of sepsis in 101 patients in the intensive 
care unit. In this study, calcitonin precursors (i.e. ProCT) showed near- optimal sensitivity 
and specificity, whereas the lactate level showed a near-random correlation. (adapted from 
Müller et al. 2000 (30)). 
 
3.2.3.1 ProCT as a toxic factor in bacterial infection and sepsis 
Circulating ProCT levels correlate with severity of the bacterial insult and with 
mortality in humans, hamsters and pigs. In septic hamsters, the levels of serum CT 
precursor peptides such as ProCT, CT:CCP-I, and N-ProCT increased markedly and 
peaked 12 h after induction of sepsis (35, 36). ProCT levels increased dose-
dependently with increased quantity of bacteria administered. Exogenous human 
ProCT increased mortality of septic hamsters but not in non-infected control animals. 
Mortality remained unchanged when mature CT was administered to septic animals 
(36-38).  
3.2.3.2 Improved survival after ProCT immunoneutralisation 
Treatment with ProCT reactive antiserum was leading to an increased survival rate in 
a hamster sepsis model of monomicrobial e. coli peritonitis and in a polymicrobial 
sepsis model puncturing a ligated coecum into pigs. Importantly, in pigs the 
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immunoneuralisation of ProCT remained effective even when the antiserum was 
administrated after the pigs became moribund (35, 38). These characteristics of 
ProCT, improving the clinical diagnosis and antibiotic stewardship in sepsis and 
bacterial respiratory tract infections and a treatable sepsis mediator in several animal 
models of mono- and polymicrobial sepsis both early and late during the course of the 
disease are unmatched by any other molecule. 
3.2.3.3 Mode of action of CT peptides 
A recent paper by Sexton et al. shed light on the molecular mechanism on the action 
of ProCT on the receptor level (39).  
Based on their structural homologies, calcitonin peptides have overlapping 
bioactivities, which they exert by binding to the same family of receptors (40). There 
are two subgroups of these G protein coupled receptors with seven transmembrane 
domains: calcitonin receptors (CR) and calcitonin receptor-like receptor (CLR). Three 
accessory proteins, receptor activity-modifying proteins (RAMPs 1–3), bind on these 
receptors and alter their specific responsiveness and ligand affinity (12). The 
presence, the concentration, and the timing of the three RAMPs determine the specific 
cellular phenotype of the receptor that is biologically active on the cell surface. 
Depending on which of the different RAMPs is associated with the receptor, different 
CT peptides bind with distinct affinities. It is tempting to speculate that the 
extraordinary increase of circulating ProCT in sepsis prevents CGRP and ADM from 
exerting their actions, and thus acts as an antagonist with or without its own agonistic 
(i.e., intrinsic) activity. ProCT was found to be a potent agonist of the CGRP1 
receptor, a weak agonist at the amylin (AMY1) receptor of medicine, and virtually 
inert at the calcitonin (CTa) and adrenomedullin (AM1, AM2) receptors, respectively, 
as assessed by cAMP production. In addition, ProCT inhibited the response to 
endogenous agonist peptides at their respective receptors, especially CGRP (CGRP1), 
and to a lesser extent also calcitonin (CTa) and amylin (AMY1) (Christ-Crain M, 
Müller B., Editorial, Crit Care Med 2008 Vol 36, No.5 ). 
3.2.4 Increased levels of CGRP and ADM in bacterial infection and sepsis 
In addition to ProCT, levels of circulating CGRP (41) and ADM (42) are elevated in 
human patients with sepsis (for CGRP from 2.0 +/- 0.3 pg/ml in control patients up to 
14.9 +/- 3.2 pg/ml in sepsis and for ADM from 7.9 +/- 3 fmol/ml in normal up to 107 
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+/- 139 fmol/ml in sepsis) but in a much lower extent than ProCT. Unfortunately, the 
measurement of ADM for diagnostic or prognostic purposes is technically challenging 
(43). Due to their potent bioactivity as vasodilators, the circulating levels of CGRP 
and ADM are much more tightly regulated as compared to levels of the less active 
ProCT. The measurement of the mature hormones, however, is cumbersome due to 
the short half-life of only few minutes. Reliable measurement is almost impossible 
because ADM is rapidly cleared from the circulation and masked by the binding 
protein complement factor H, making it inaccessible for immunometric analysis (20, 
44).  Recently, the more stable midregional fragment of pro-adrenomedullin (MR-
ProADM) was identified in plasma of patients with septic shock and shown to be a 
useful prognostic marker (43). In this context, elevated levels of MR-ProADM have 
been shown to be helpful for individual risk assessment and outcome prediction in 
sepsis (43, 45, 46). 
3.2.5 Extrathyroidal expression of CALC gene mRNA and CT precursor 
peptides in bacterial infection and sepsis  
Muller et al. (23) identified a uniform and ubiquitous expression of CT-mRNA in 
tissue of septic hamsters. The expression pattern of CT-mRNA is more specifically 
increased in sepsis compared to that of other established pro-inflammatory mediators 
of systemic infection such as TNF-α and IL-6, meaning that high levels of TNF-α and 
IL-6 mRNA expression are already present in several tissues of the non-septic, 
apparently healthy control animals (Figure 6). This ubiquitous sepsis-induced 
expression pattern characteristic for hormokines is also present in other species, 
namely pigs (25) and primates (26) including humans (28, 47). 
Similar as for CT, mRNA of the second CALC-I gene splicing product CGRP-I is 
present in several tissues of septic hamsters compared to healthy control animals and 
here as well, CGRP mRNA is more specifically up-regulated than the mRNA of TNF-
α and IL-6 (24). In septic humans, serum levels of CGRP also increase (41), but the 
levels are considerably lower as compared to the level of the CT precursor peptides. 
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Figure 6: CT- , CGRP-I and cytokine mRNA expression in septic and control hamsters. 
Total RNA was extracted from the different control and septic tissue. For all different PCR-
products, the specificity was verified by direct sequencing of DNA from four randomly 
chosen tissues with a positive signal. To facilitate comparison, the control and septic tissues 
were aligned for each PCR- product. (Suarez Domenech et al. 2001(24)). 
 
3.3 Infection and sepsis-related expression of CT peptides in adipose 
tissue  
3.3.1 Human adipose tissue 
The composition of adipose tissue is complex. Heterogenous and many different cell 
types including adipocytes, preadipocytes, pericytes, monocytes, macrophages and 
cells of the endothelium such as endothelial and vascular smooth muscle cells form 
adipose tissue. Adipocytes are the most predominant cells and the additional cells are 
collectively referred as the stromal vascular cell fraction (SVF).  
Adipose tissue is known to act as an endocrine organ actively participating in the 
regulation of a variety of physiologic and pathologic processes, including immunity 
and inflammation. Adipose tissue contributes to the immune response through direct 
effects caused by several cell types of the SFV, among which are cells of the immune 
system. On the other hand, preadipocytes and adipocytes themselves are important 
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contributors to some aspects of the immune system. Like macrophages, they are 
sensitive to infectious disease agents and cytokine-mediated inflammatory signals 
(48). Preadipocytes and adipocytes express a broad spectrum of Toll-like receptors 
(TLRs) and preadipocytes can convert into macrophage-like cells (49, 50). Adipose 
tissue produces and releases a variety of pro-inflammatory and anti-inflammatory 
factors, including the adipokines leptin, adiponectin, resistin, and visfatin, which 
regulate monocyte and macrophage function, as well as cytokines and chemokines, 
such as TNF-α, IL-1β, IL-6, IL-8, monocyte chemoattractant protein 1 (MCP-1), and 
others (51, 52).  
3.3.2 Inflammatory signaling in adipocytes 
TLRs are a class of proteins which play a key role in innate immunity. They belong to 
a family of transmembrane proteins characterized by an extracellular domain 
composed of leucine-rich repeats and a Toll-IL-1R domain in their cytoplasmic 
region. Each of them is specialized in the recognition of a particular subset of 
pathogen-associated molecular patterns (PAMPs). Their activation by various ligands 
triggers a signaling cascade leading to cytokine production and initiation of an 
adaptive immune response (53). The description of the TLRs, including their role, has 
mainly been determined in immune cells (54), but these receptors are also expressed 
by several other cell types, such as epithelial cells (55) keratinocytes (56) and 
adipocytes (57), whereby in adipocytes the two receptors TLR2 and TLR4 have been 
shown to be present. 
TLR4 is the receptor for the bacterial endotoxin LPS and plays a critical role in the 
nuclear factor kappa B (NFκB) and MAP kinase signaling pathways. Stimulation of 
TLR4 by LPS activates pro-inflammatory pathways, whereby one is activated by the 
adaptors TIRAP (Toll/interleulin-1-receptor (TIR)-domain-containing-adaptor 
protein) and MyD88, which induces the expression of cytokines such as IL-6, IL-1β 
and TNF-α. TLR4 activation also leads to the induction of type I interferons (INF) 
such as INF-β (58) (Figure 4). 
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Figure 4: TLR4 signaling. Binding of LPS on TLR4 induces expression of pro-inflammatory 
cytokines such as IL-1β, TNF-α and IL-6 and of INF-β. TLR proteins utilize the adapter 
protein MyD88 to activate a signaling pathway leading to the activation of the transcription 
factor NF-κB and MAP kinases in a TRAF-6-dependent manner. These signaling events 
culminate in expression of the pro-inflammatory cytokines IL-1β and TNF-α. TLR4 uses an 
additional adapter molecule, called TIRAP, to induce the expression of IL-6 and IFN-β 
(adapted from Armant and Fenton 2002 (58)). 
 
Most of the TNF-α mRNA in adipose tissue is found within adipocytes (59, 60) and 
Hoch et al. (61) demonstrated in adipose tissue explants an increased secretion of the 
cytokines IL-6, IL-8, IL-10 and TNF-α upon LPS and in preadipocyte- or MSC- 
derived adipocytes a dose dependent release of IL-6 and IL-8 induced by LPS.  
3.3.3 Adipocytes and CT peptides  
Adipose tissue is an important extrathyroidal source of CT peptides during bacterial 
infection and inflammation. The increase in ProCT occurs both in subcutaneous and 
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omental fat depots. Linscheid et al. (47) measured increased CALC-I gene expression 
in adipose tissue samples from infected compared to noninfected patients with 
different levels of serum ProCT.  Adipocyte selecting ceiling-cultures confirmed that 
the source of CALC gene products is from adipocytes directly and not from non-
adipose cells potentially present in their tissue and cell-culture model such as 
macrophages or endothelial cells (47).  Upon inflammatory stimuli such as bacterial 
LPS and of LPS, IL-1β and TNF–α in combination, MSC-derived adipocytes were 
shown to express mRNA and secrete protein of CT, CGRP (-I and –II) and the 
CALC-V gene ADM in vitro (28). 
 
3.4. CALC genes and calcium  
3.4.1 Hypocalcemia in sepsis 
In critically ill patients, especially in those with sepsis and major burn injuries 
hypocalcemia is a common phenomenon and indicates an adverse outcome (62-64) . 
Several factors may be involved, including resistance to parathyroid hormone (PTH) 
action in the kidney and bones, an impaired vitamin D metabolism and function or the 
chelation of calcium by lactate. Additionally, CT precursors which are increased in 
the circulation of critically ill patients with sepsis are suspected to contribute to 
hypocalcemia (64).  
While sepsis is accompanied by a decrease in extracellular Ca2+ concentration levels 
([Ca2+]e) , increased intracellular calcium concentrations ([Ca2+]i) have been observed 
in parallel. In the aortic smooth muscles of septic rats, [Ca2+]i is increased more than 
2-fold during sepsis (65). The increase in the activity of calcium-activated enzymes in 
tissues of septic animals such a the calcium-activated protease calpain (66) and 
glycogen phosphorylase b kinase (67) also explains the elevated [Ca2+]i in sepsis. Not 
only in animal models but also in human cells an increase in [Ca2+]i can be observed 
in septic patients compared with healthy control patients or cardiac surgical and head-
injured patients (68). 
3.4.2 Calcium 
Calcium is one of the major elements of the body and plays an essential role in the 
mineral hydroxypatite which gives rigidity to the skeleton. The skeleton can be 
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denoted as a valuable mineral reservoir, since a vast majority of the total body 
calcium is stored in bones whereby 99% is tied up in the mineral phase and the 
remaining 1% is in a pool that can rapidly exchange with extracellular calcium. 
However, besides the skeleton, there are two not less important pools of calcium in 
the body, namely the calcium in the blood and extracellular fluid and the intracellular 
calcium. Ionized calcium (Ca2+) plays a crucial role in many physiological and 
cellular processes which include neuromuscular excitability, membrane permeability, 
muscle contraction, blood clotting, enzymatic activation and regulation of gene 
expression. There are three forms of circulating calcium in the blood; roughly 50% of 
the calcium in blood is bound to proteins, 10% in a diffusible but non-ionized chelated 
fraction and 40% in an ionized fraction. The concentration of ionized calcium is 
constant at approximately 1 mM, or 10,000 times the basal concentration of free 
calcium within cells. In contrast, [Ca2+]i  fluctuate greatly, from around 100 nM to 
greater than 1 µM, due to release from cellular stores or influx from extracellular fluid 
(64, 69). A large majority of intracellular calcium is sequestered in the endoplasmic 
reticulum and in mitochondria. The cytoplasmatic calcium level is low in resting cells 
and maintained at 100 nM by extrusion via plasma membrane calcium pumps 
(PMCA) and sarco-endoplasmic reticulum Ca2+ ATPases (SERCA). Additionally, the 
sodium/calcium exchanger (NCX) is a major secondary regulator of [Ca2+]i and is 
exchanging three Na ions for one Ca2+. Calcium-binding proteins in the cytoplasm 
and in the endoplasmic reticulum (ER) offer additional Ca2+ buffering capacity. 
[Ca2+]i can increase through release from ER stores through the ryanodine (RyR) and 
inositol-1,4,5-trisphosphate receptors (IP3R) and through calcium influx from 
extracellular pools through various channels (voltage-, receptor- or store-operated 
channels) and, under extreme circumstances, through the NCX. Additionally, 
increased [Ca2+]i drives Ca2+ overload in mitochondria through mitochondrial 
membrane calcium pump (MMCA), and relaxed specificity channels (uniporter). In 
turn, calcium overload triggers secondary release of Ca2+ from mitochondrial stores, 
through the mitochondrial NCX (MNCX) and mitochondrial pores opened during 
mitochondrial permeability transition (MPT) (Figure 5) (70).  
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Figure 5: Mechanisms of calcium homeostasis. [Ca2+]i increase through ryanodine receptor 
(RyR), and inositol-1,4,5-trisphosphate receptors (IP3R) in the endoplasmatic reticulum, 
through influx through voltage-, receptor- or store-gated channels and through the 
sodium/calcium exchanger (NCX). Ca2+ enters mitochondria through mitochondrial 
membrane calcium pump (MMCA) and relaxed specificity channels (Uniporter) and triggers 
secondary release of Ca2+ from mitochondrial stores, through the mitochondrial NCX 
(MNCX) and mitochondrial pores opened during mitochondrial permeability transition 
(MPT). The plasma membrane calcium pump (PMCA), NCX and sarco-endoplasmic 
reticulum Ca2+ ATPase (SERCA) restore normal calcium levels. Calcium-binding proteins in 
the cytoplasm and in the endoplasmatic reticulum act as calcium buffers (adapted from 
Syntichaki P. et al. 2003 (70)). 
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3.4.3 Calcium and CALC genes 
3.4.3.1 Calcium and CT 
The calcium-sensing receptor (CASR) is expressed in CT-producing C-cells, in 
parathyroid hormone (PTH) -producing cells of the parathyroid gland, and in the cells 
lining the kidney tubule. The CASR is a plasma membrane G protein-coupled 
receptor which senses small changes in circulating calcium concentration and 
stimulates CT secretion and suppresses PTH secretion. The CT release occurs within 
minutes of the elevation of plasma calcium and CT acts promptly to suppress calcium 
release from bones and inhibits tubular reabsorption in the kidney (71-73). 
Conversely, increased expression of the CASR leads to a decrease in the extracellular 
calcium set-point, thereby reducing PTH secretion and renal calcium reabsorption and 
increasing CT secretion (74, 75). Conversely, decreased calcium binding on the 
extracellular side induces a conformational change of the receptor, which, on the 
intracellular side, initiates the phospholipase C pathway (76), ultimately increasing 
[Ca2+]i, triggering vesicle fusion and exocytosis of PTH. 
In contrast to the persistent hypercalcaemic effects of PTH and 1,25-
dihydroxyvitamin D3 the calcium-lowering hormone CT is only mild and transient. 
Basically, the true function of CT in humans remains enigmatic (77). In patients with 
MTC, which is a malignancy of the C-cells, large amounts of CT are secreted, but 
surprisingly no hypocalcemia occurs (78). Similarly, decreased levels of CT after 
thyroidectomy are not accompanied by elevations in serum calcium concentration 
(79).  In the blood of MTC patients, the 116-amino-acid CT precursor peptide ProCT 
is universally present. High ProCT to CT ratios were prognostic and correlated with a 
high risk for progressive disease and a shorter progression-free survival (80, 81). 
3.4.3.2 Molecular mechanism of CT expression 
The molecular entity through which C-cells detect changes in [Ca2+]e and modulate 
hormone secretion is unknown. Additionally, the molecular mechanism underlying 
the CT gene expression dependent on Ca2+ has not yet been clarified. 
DREAM (downstream regulatory element antagonist modulator) was first identified 
as a Ca2+-dependent transcriptional repressor of the prodynorphin gene. DREAM has 
a mass of 29 kDa, four EF hand motifs, and is the first known Ca2+-binding protein to 
function as a DNA binding transcriptional regulator (82). The prodynorphin gene 
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contains a consensus DNA sequence called downstream regulatory element (DRE), 
and its transcription requires direct association with DREAM. The Ca2+-unbound 
DREAM binds to the DRE site as a tetramer and represses the transcription of target 
genes (Figure 6, left panel). An increase in the [Ca2+]i causes the dissociation of the 
Ca2+-bound DREAM from the DRE site and results in transcriptional derepression 
(Figure 6, right panel). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6: Repression-derepression mechanism driven by DREAM on a potential target 
gene. Under basal conditions, DREAM is bound to the promoter DRE as a tetramer and gene 
transcription is repressed (left panel). [Ca2+]i increase abolishes DREAM-DNA binding, 
resulting in derepression of gene transcription (right panel). 
 
DREAM is highly expressed not only in the brain but also in the thyroid glands in 
human tissues (82) including TT cells (83). This human thyroid carcinoma cell line 
lacks the extracellular calcium-sensing function but secrets constituently large 
amounts of CT and its precursors. Two DRE core sequences are present in the 5’-
flanking region of the CALC-I gene. Thus, DREAM might play a role in human CT 
gene expression in TT cells. Furthermore it has been shown that DREAM binding to 
DRE sites is not only regulated by Ca2+ but also by specific protein-protein 
interactions with nuclear factor effectors of the cyclic AMP (cAMP) pathway and 
these interactions are independent of nuclear Ca2+ (84). Cellular stimulation by 
hormones or activation of membrane receptors is often followed by an elevation of 
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both second messengers Ca2+ and cAMP, indicating that both mechanisms can 
cooperatively derepress DRE-dependent transcription. 
3.4.3.3 Calcium and CGRP 
Although most of the body CGRP is of neural origin, the CALC-I gene in the thyroid 
C-cells is also generating mRNA encoding for CGRP-I and the CGRP peptide is also 
stored within secretory vesicles of the C-cells. Normally, administration of Ca2+ does 
not induce increases in the plasma CGRP concentrations, which was shown in several 
in vivo studies in rats (85, 86). But in humans with low blood pressure, an increase in 
CGRP has been observed upon elevated Ca2+(87). In vitro studies in mice, neonatal 
rats and dogs demonstrated that Ca2+ stimulates the secretion of CGRP from thyroid 
glands (88-90).  
Conversely, CGRP has been shown to trigger transient increases in [Ca2+]i in 
astrocytes and glia cells (91). 
3.4.3.4 Calcium and ADM 
In adrenal chromaffin cells ADM is stored in the secretory vesicles to be co-secreted 
with catecholamines. Catecholamine secretion and activation of catecholamine 
biosynthesis has been shown to result from an increase in the [Ca2+]i and ADM has 
been shown to stimulate Ca2+ efflux from adrenal chromaffin cells, probably through 
acceleration of  Na+/Ca2+ exchange (92). Additionally, ADM has been shown to 
induce a [Ca2+]i increase in bovine aortic endothelial cells in a dose-dependent manner 
(93). The same increasing effect of ADM on [Ca2+]i has been described in a human 
oligodendroglial cell line (94). In contrast, in hippocampal neurons (95) and retinal 
pigment epithelial cells (96), ADM has been shown to have an effect on [Ca2+]i the 
opposite way around, namely to reduce
 
[Ca2+]i and to inhibit Ca2+ release from 
intracellular stores. Although numerous studies exist on the effect of ADM on [Ca2+]i, 
even with conflictive conclusions, little or nothing is known on the effect of [Ca2+]i on 
ADM. 
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3.5 CALC genes and cAMP 
3.5.1 cAMP 
Similar to Ca2+, cAMP is an archetypic second messenger. It impacts on every aspect 
of the life of the cell, from differentiation and development through to cell death. 
cAMP is derived from adenosine triphosphate (ATP) and produced by enzymes of the 
adenylat cyclase (AC) family. In turn, the phosphodiester bond in cAMP gets 
degraded by enzymes called phosphodiesterases (PDE) which thereby regulate the 
localization, duration, and amplitude of cyclic nucleotide signaling within subcellular 
domains. cAMP is involved in the activation of several protein kinases (PK) (i.e. PKA 
and PKC), regulates the effects of different hormones such as adrenalin and glucagon 
and regulates the passage of Ca2+ through ion channels. To date, different isoforms of 
ACs have been described, namely 9 membrane-bound (AC1-9) and one soluble form. 
ACs are regulated by a range of signaling molecules and hormones in a stimulatory or 
inhibitory manner through the mediation of stimulatory and inhibitory G-proteins 
(97). 
3.5.2 cAMP and calcium 
Among the membrane-bound ACs, many of them have been found to be regulated by 
[Ca2+]i, whereby some are stimulated and  others are inhibited by Ca2+ (Table 1). 
AC2, AC4, AC5 and AC6 mRNAs are significantly transcribed in white adipose 
tissue from rats (98). AC2 mRNA amount decreases from the undifferentiated to the 
late differentiated state. Conversely, AC4, AC5 and AC6 mRNA are more expressed 
in late differentiated preadipocytes and mature adipocytes compared to 
undifferentiated preadipocytes. Apparently, the different AC isoforms described in 
adipose tissue are either inhibited by Ca2+ or they are Ca2+- insensitive. In hamster 
adipocytes it has been described that increasing [Ca2+]i results in stimulation of PDE 
and a decrease in cAMP levels (99) . 
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AC isoform Major source of expression Response to Ca2+ 
AC1 brain Stimulation  
AC2 lung, brain, preadipocytes No effect 
AC3 olfactory epithelium, pancreas Stimulation or 
inhibition 
AC4 Widespread, adipocytes No effect 
AC5 heart, striatum, adipocytes Inhibition 
AC6 heart, kidney, widespread, 
adipocytes 
Inhibition 
AC7 widespread No effect 
AC8 brain, pancreas Stimulation 
AC9 Testis, widespread inhibition 
 
Table 1: Major sources of expression of each of the nine membrane-bound AC isoforms 
(adapted from Willoughby and Cooper, 2006 (97)). 
 
IP3-mediated Ca2+ release from the ER has the potential to act as a weak regulator of 
Ca2+ -sensitive ACs and in nonexcitable cells, only the Ca2+ entry pathway occurring 
via store-operated Ca2+ channels has been shown to regulate AC activity (Figure 7).  
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Figure 7: Ca2+ regulation in nonexcitable cells and effects on AC activity. IP3 –mediated 
Ca2+ release from the endoplasmatic reticulum and Ca2+ entry via store-operated calcium 
channels regulates the activity of Ca2+ -sensitive ACs (adapted from Willoghby D. and 
Cooper D. 2007 (97)). 
 
3.5.3 cAMP and DREAM 
In addition to the DRE motif in the 5’ flanking region of the CALC-I gene, cAMP 
responsive element (CRE) and CRE-like motifs have been identified in the same 
region and shown to be involved in transcriptional activation (100). cAMP-dependent 
gene expression is controlled at the transcriptional level by several leucine zipper 
transcription factors, including the cAMP responsive element binding protein (CREB) 
and cAMP responsive element modulator (CREM) which bind to CRE sites in target 
genes (101).  
In human neuroblastoma cells, PKA activation by cAMP has been shown to result in 
loss of DREAM binding to the DRE motif and derepression of the target gene 
prodynorphin (102), both Ca2+-dependent (103) and independent (84). 
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3.5.4 cAMP and CALC genes  
Binding of CT to the CT receptor initiates cAMP responses in kidney cells, bone cells 
and in a human lymphoid cell line (104-106). In the lymphoid cell line, the formation 
of cAMP was suppressed by increased [Ca2+]i. CGRP binding to its receptor results in 
increased cAMP levels in different cell types (107, 108) and CGRP dose dependently 
elevates cAMP levels in kidney cells (109). In several cell types, the CALC-V gene 
product ADM stimulates the formation of cAMP, up to 10 fold stronger as compared 
to CGRP (110-113).  
Conversly, cAMP, similar to Ca2+, has an impact on CALC gene expression. cAMP 
enhances transcription of CT and CGRP mRNA in TT cells (100, 114) and CREB is a 
possible candidate to mediate cAMP induced transcriptional activation of the CALC-I 
gene.  
 
 
Aim of the thesis 
_____________________________________________________________________ 
 29 
3.6 Aim of the thesis 
 
In human adipose tissue of septic patients and in a model of human preadipocyte- 
or MSC-derived adipocytes CALC gene expression and CT protein content 
increase upon stimulation with bacterial endotoxin and pro-inflammatory 
cytokines. The molecular mechanisms as to how bacterial infection stimulates this 
extrathyroidal CALC-gene expression are unknown so far. Thus, the aim of this 
thesis was to gain a better understanding of the regulation of CT peptides during 
bacterial infection and inflammation in our well established human adipocytes 
model. 
• The main focus of this work was to study the effect of the bacterial endotoxin 
LPS as a model for bacterial infection on intracellular calcium concentration 
changes in our adipocyte cell cultures in respect to alterations in CALC-I and 
CALC-V gene expression  
• Additionally we wanted to explore the effect of cAMP on CALC gene 
expression and the effect of LPS on cAMP levels in human adipocytes. 
 
Minor aims of this thesis were the following: 
• to evaluate the differentiation capacity of preadipocytes in our cell culture 
model 
• to exclude cytotoxic effects of LPS on adipocytes  
• to evaluate involvement of the NFκB pathway in LPS-induced CALC-I gene 
expression 
• to examine whether the LPS-mediated effect on CALC-I gene expression is 
due to IL-1β 
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4. Materials and Methods 
4.1 Cell culture 
4.1.1 Primary human adipocyte cell culture model 
The stromal-vascular cell fraction (SVF) containing preadipocytes was isolated from 
fat tissue from lean and from obese donors during elective abdominal surgery 
indicated for various non-malignant conditions (27). The study was approved by the 
local ethics committee and informed consent has been obtained from the patients. 
Bone marrow aspirates (20-40 ml) were obtained from healthy donors (18-63 years) 
during routine orthopedic surgical procedures, in accordance with the local ethics 
committee (University Hospital Basel, Switzerland) and after informed consent. 
Nucleated cells were isolated from the aspirate by Ficoll density gradient 
centrifugation (Histopaque1, Sigma, Buchs, Switzerland). Human mesenchymal stem 
cells (MSC) were selected within the nucleated cells in culture by adhesion and 
proliferation on the plastic substrate.  
The SVF or the MSC cells were expanded in vitro in DMEM (Lonza, Verviers, 
Belgium) supplemented with 10% fetal bovine serum (FBS) and 5 ng/mL β-FGF 
(Lubio Science, Luzern, Switzerland). For experiments, cells from different donors 
between passages 3 and 8 were seeded into 6-well or 12-well plates.  Differentiation 
into adipocytes was induced by incubating confluent cells in DMEM/F12 (Lonza) 
containing 3% FBS and supplements as follows: 30 mM HEPES (Lubio Science), 250 
µM 3-isobutyl-1-methylxanthine (IBMX), 1 µM dexamethasone, 0.2 nM 3,3,5-
triiodo-L-thyronine, 5 µM transferrin, 8 µg/ml biotin , 15 mM D-pantothenat (all from 
Sigma-Aldrich, Buchs, Switzerland), 100 nM insulin (Novo Nordisk, Küsnacht, 
Switzerland), 1 µM rosiglitazone (GlaxoSmithKline, Worthing, UK). After 10–14 
days, supplements were removed by washing two times with warm phosphate 
buffered saline (PBS) and DMEM/F12 containing 3% FBS was then added. 
Experiments were started 3 days after completing differentiation. 
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4.1.2 HEK293T and TT cells 
Cells of the human embryonic kidney (HEK) cell line HEK293T (ATCC; SD3515) 
were cultured in DMEM medium supplemented with 10% FBS in 100 mm 
petridishes. 
Human medullary thyroid carcinoma cells (TT cells line, kindly provided by Prof. A. 
Russo, Iowa City, Iowa, USA) were cultured in RPMI 1640 medium (Lucerna AG) 
supplemented with 10% FBS. 
4.1.3 Splitting, freezing and thawing of cells  
4.1.3.1 Splitting  
At 80 % confluence, cell layers were rinsed twice with pre-warmed PBS
- 
and 
trypsinised with a solution consisting of a mixture of trypsin/EDTA/PBS to disrupt 
cell-cell and cell-substratum interactions. The trypsin was inactivated by the addition 
of DMEM.  
4.1.3.2 Freezing 
Cells were treated as above, and collected by centrifugation (200 rpm for 5 min). The 
pellet was resuspended in cold freezing media (normal medium supplemented with 
FCS and 10% DMSO). Cells were then transferred into cryo-tubes (Nunc), placed in a 
Styrofoam box and slowly frozen at -80°C. For long-term storage, cryo-tubes were 
transferred to liquid nitrogen.  
4.1.3.3 Thawing  
Cells were thawed at room temperature and quickly transferred to a Falcon tube 
containing 5 ml of pre-warmed DMEM + 10% FCS. After centrifugation, the 
supernatant was removed and the cell pellet was resuspended in DMEM +10%FCS. 
Cells were seeded into cell culture dishes and grown in an incubator at 37°C + 5% 
CO2. 
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4.2 RNA and DNA applications 
4.2.1 RNA isolation 
Total RNA was extracted from 6-well or 12-well cell culture plates using the 
following protocol:  
Homogenization:  
First, the cell culture medium was removed. The cells were then lysed by adding 1 ml 
TRI® Reagent (Sigma-Aldrich, St. Louis, MO, USA) directly into the well. The cell 
lysate was passed several times through a pipette, transferred to a 2 ml Eppendorf® 
tube and homogenized by douncing it through a RNase-free 23-gauge needle using a 
syringe. 
 
Phase Separation:  
The homogenate was stored for several hours at -80°C to permit complete freezing of 
the samples. Next, the homogenate was unfrozen, supplemented with 0.1 ml 1-
Bromo-3-Chloro-Propane per 1 ml of TRI Reagent, covered tightly and shaked 
vigorously for 15 sec. The resulting mixture was stored at room temperature for 2-15 
min and then centrifuged at 14000 g for 15 min at 4°C in an Eppendorf centrifuge 
5417R. Following centrifugation, the mixture separates into a lower red phenol-
chloroform phase, interphase and the colorless upper aqueous phase. RNA remains 
exclusively in the aqueous phase whereas DNA and proteins are in the interphase and 
organic phase.  
 
RNA Precipitation:  
The aqueous phase was transferred to a Biosphere Safeseal Micro tube. RNA from the 
aqueous phase was precipitated by mixing with 0.5 ml of isopropanol. Samples were 
stored at -20°C for 20 min and then centrifuged at 14000 g for 15 min at 4°C 
 
RNA Wash:  
The supernatant was removed and the RNA pellet washed with 1ml of 75% ethanol 
and then centrifuged at 14000 g for 5 min at 4°C.  
 
RNA elution:  
Ethanol was removed and the RNA pellet was air dried for 5 min and briefly at 65°C.  
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The RNA was dissolved in RNase-free water and incubated for 10 min at 65° C and 
then directly put on ice. 
RNA concentration and purity was measured using the NanoDrop ND-1000 
Spectrophotometer. 
4.2.2 cDNA synthesis 
Specific PCR thin wall tubes with flat caps (Sarsteadt) were used. 
1 µg of total RNA was reverse transcribed using the High Capacity cDNA RT Kit 
from Applied Biosystems. The RNA was mixed with 2 µl 10x RT buffer, 0.8 µl 25x 
dNTP mix (100mM), 2 µl 10x RT Random Primers and 0.5 µl RNase inhibitor (10000 
U) and 3.7 µl nuclease-free H2O up to a final volume of 20 µl. The mix was incubated 
for 10 min at 25°C, followed by incubation for 120 min at 37°C. To inactivate the 
enzyme reaction, the samples were heated at 85°C for 5 sec and the stored at -20°C. 
4.2.3 Real-time polymerase chain reaction (RT-PCR) 
For quantitative PCR, optimal sets of primers were designed for each studied gene 
using the “ProbeFinder” (Roche Applied Bioscience) website interface 
(http://qpcr2.probefinder.com ) and synthesized by Microsynth. 2 µl cDNA, 1 µl 
SYBR Fwd primer (from 10 µM stock), 1 µl SYBR Rev primer (from 10 µM stock), 
and 12.5 µl of Power SYBR Green PCR Master Mix from Applied Biosystems were 
mixed and adjusted to a final volume of 20 µl with H2O.The reaction was performed 
following the manufacturer’s instructions on a 7500 Fast Real Time PCR system 
Thermal Cycler from Applied Biosystems and the 7500 Fast System SDS analysis 
software.  
The primers used were the following: 
 
CT sense primer, 5’-GTGCAGATGAAGGCCAGTGA- 3’  
CT antisense primer 5’-TCAGATTACCACACCGCTTAGATC- 3’ 
CGRP-I sense primer, 5’-CCCAGAAGAGAGCCTGTGACA- 3’  
CGRP-I antisense primer: 5’-CTTCACCACACCCCCTGATC- 3’   
ADM sense-primer, 5’-ACTTGGCAGATCACTCTCTTAGCA- 3’  
ADM antisense primer 5’-ATCAGGGCGACGGAAACC- 3’  
IL-6 sense primer 5’-TCTTCAGAACGAATTGACAAACAAA- 3’ 
IL-6 antisense primer 5’-GCTGCTTTCACACATGTTACTCTTG- 3’ 
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IL-1β sense primer 5’-AGCTGATGGCCCTAAACAGA- 3’ 
IL-1β antisense primer 5’ -TCG GAG ATT CGT AGC TGG AT- 3’ 
HPRT sense primer, 5’-TCAGGCAGTATAATCCAAAGATGGT- 3’ 
HPRT antisense primer, 5’-AGTCTGGCTTATATCCAACACTTC- 3’ 
 
4.3 Bacterial transformation 
4.3.1 Vector information  
53RPA-PGK-GFPas: (6.93 kb) was provided by Prof. Patrick Salmon, University of 
Geneva, Switzerland. This vector contained an ampicillin resistance gene sequence 
and different CALC-I gene promoter deletion constructs cloned into the XhoI 
restriction site by Dalma Seboek and Kathrin Boelsterli. 
4.3.2 Competent cells 
Escherichia coli HB101 were ordered from Promega (Promega Corpoation, 
Madison,WI, USA) and stored at -70°C.  
4.3.3 Plasmid transformation into bacteria 
The competent cells were thawed on ice for about 5 min, gently mixed by flicking the 
tube and 100 µl were transferred into chilled culture tubes. 1-50 ng of plasmid DNA 
was added and incubated on ice for 10 min before heat shocking at 42°C for 45-50 
sec. The mix was put back on ice for 2 additional min, then re-suspended in 900 µl of 
chilled antibiotic-free LB medium and incubated for 60 min at 37°C with shaking. 
The cells were plated on LB-plates containing the appropriate antibiotics and 
incubated overnight at 37°C. 
4.3.4 Plasmid amplification and purification 
4.3.4.1 Small scale purification miniprep (Mini-Prep) 
Bacterial colonies were picked from the agar plates with a sterile toothpick and 
transferred into sterile polypropylene culture tubes (Becton Dickinson Labware, Le 
Pont De Claix, France) containing 3 ml LB medium containing the plasmid-related 
antibiotic ampicillin. The mix was incubated overnight at 37°C on a shaker (200 rpm). 
Materials and Methods 
_____________________________________________________________________ 
 35 
Plasmids were purified from this culture using the NucleoSpin® plasmid purification 
kit (Machery-Nagel, Düren, Germany) according to the manufactor’s protocol. Inserts 
were then checked by DNA digestion. 
 
4.3.4.2 Large scale purification (Maxi-Prep) 
Large scale DNA extraction was performed using the commercial kit NucleoBond® 
PC 500 from Machery-Nagel according to the manufacturer's instructions. Maxi-preps 
were done with the overnight culture grown in 100 ml LB medium containing 
ampicillin. 
4.3.5 DNA digestion  
Plasmid DNA products were digested in a buffer containing the adequate restriction 
enzyme(s), double-distilled water and BSA, if required. Incubation time and 
temperature varied according to the enzyme(s) used.  
4.3.6 Agarose gel eletrophoresis  
Samples were analyzed by running an aliquot of the digestion products in an agarose 
gel containing 0.5 µg/ml of ethidiumbromide. 1% agarose gels were prepared by 
weighing agarose (Agarose LE, Analytical Grade, Promega) in TBE buffer and 
boiling the mixture in a microwave oven. Before casting the gel, ethidiumbromide 
(Biorad, Reinach, Switzerland) was added to the mixture. Loading-buffer was added 
to the samples and gels were run at 80 V for approximately one hour. To visualize the 
DNA, an UV transilluminator was used. 
 
4.4 Cytosolic Ca2+ measurements by confocal microscopy 
[Ca2+]i in human preadipocyte-derived adipocytes was measured using a dual-
excitation fluorescence imaging system with a cell permeant acetoxymethyl ester of 
the coumarin benzothiazole–based Ca2+ indicator (BTC AM, Lubio Science, Luzern, 
Switzerland ). Alternatively, the cells were loaded with Fluo-3 AM or Fura-2 AM 
(both from Lubio Science). Preadipocytes were plated into 2- well or 4-well glass 
chamber slides (NC-155380K, Nunc, Rochester, NY, USA) and differentiated into 
adipocytes as described before. Fully differentiated adipocytes were washed twice 
with a modified Krebs-Ringer buffer (MgSO4 1,2 mM, KCl 4,8 mM, KH2PO4 1,2 
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mM, NaHCO3 20 mM, NaCl 118 mM, CaCl2 2,5 mM and D-Glucose 1.8 g/l, pH 7.4). 
Cells were loaded alternatively with BTC AM, Fluo-3 AM or Fura-2 AM (all at 3 
µM) in the same buffer for 30 min at 37°C in a dark incubator with 5% CO2. To 
remove extracellular dye, cells were rinsed twice with pre-warmed modified Krebs-
Ringer buffer and then post-incubated at 37°C in a dark incubator with 5% CO2 for a 
minimum of 30 min before ionomycin or LPS infection for complete hydrolysis of 
cytoplasmic BTC AM, Fura-2 AM or Fluo-3 AM, respectively.  
The chamber slide was mounted in an incubation chamber on a 40x oil-immersion 
objective, and the chamber was thermostatically regulated at 37°C with 5% CO2. 
Images were acquired using the live cell imaging mode of a confocal laser scanning 
microscope (LSM700, Zeiss, Feldbach, Switzerland). Using BTC AM, fluorescent 
images were captured alternatively at excitation wavelength of 405 and 488 nm and 
the emission filtered at wavelength of 520 nm. Using Fluo-3 AM, cells were excited at 
488nm and for Fura-2 at 405nm. Each analysis evaluated changes in fluorescence 
intensity of 8 representative whole cells (4 used as untreated control, 4 used for 
treatments). Images of each single cell were acquired every 3 min. Fluorescence 
intensity and the curve of time course were analyzed by the Zen 2008 software 
automatically. 
 
4.5 Flow cytometry  
4.5.1 Quantification of differentiation capacity 
Preadipocytes were plated into 12-well plates and differentiated into adipocytes as 
described before. Three days after complete differentiation, cells were treated with 
different doses of LPS for 24 h, with 1 µM of ionomycin for 24 h or 3 h and with LPS 
and ionomycin in combination. After the accordant incubation times, the cells were 
washed two times with PBS at room temperature. Cells were incubated with Bodipy 
493/503 (1:4000 in PBS) for 20min at room temperature and then washed again two 
times with PBS. Cells were detached with 0,4 ml/well of 0,5 g/l EDTA and 
transferred into FACS tubes containing 1,6 ml PBS + 0,5% BSA. The samples were 
mixed and analyzed by passing through a FACSCalibur flow cytometer. 
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4.5.2 Assessment of cell viability 
Cells were handeled as described in upper section. 8 µl of propidium iodide staining 
solution (PI solution) were added to each sample, the samples were mixed and 
analyzed by passing through a FACSCalibur flow cytometer. 
4.5.3 Transfection efficiency 
MSC-cells were seeded into 175 cm3 culture flasks and differentiated into adipocytes 
as described before. After complete differentiation, the cells were infected with 15ml 
medium containing the lentiviral construct over night. On the following day, infected 
adipocytes were washed with pre-warmed PBS and maintained in adipogenic 
differentiation medium with 3% FBS for five days. The cells were then washed two 
times with PBS at room temperature, detached with 5ml trypsin, centrifuged, trypsin 
was removed, the cells were resuspended in 1,6 ml PBS + 0,5% BSA and transferred 
into FACS tubes. The samples were mixed and analyzed for green fluorescent protein 
(GFP) activity by passing through a FACSCalibur flow cytometer. 
 
4.6 Cell transfections 
4.6.1 Generation of recombinant lentiviruses 
Lentivirus production was carried in HEK293T cells and the transient transfection of 
the plasmid was achieved by the calcium chloride method. 20 µg of a plasmid 
containing GFP under the control of the phosphoglyceratekinase (PGK) promoter 
(53RPA-PGK-GFPas), 5 µg of the envelope vector pMD2.G and 15 µg of the 
packaging vector psPAX2 were mixed and the volume was adjusted to 250 µl with 
special water. 250 µl of 0.5 M CaCl2 were added and the mixture was dropped slowly 
onto 500 µl HeBS2x while vortexing top speed. To allow optimal formation of the 
precipitate, the mixture was let still for 20 to 30 min. The precipitate was added 
slowly on the cell monolayer.  
On the next day, cells were checked for visibility of a fine sandy precipitate and 
medium was changed. Virus containing supernatants were collected on day 2 and 3 
post transfection, spun at 2500 rpm for 10 min at 4°C, filtered through 0.45 µm filter, 
pooled  and kept on -80°C freezer until the start of the experiments. 
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4.6.2 Infection of cells 
Infection of differentiated TT cells or MSC- derived adipocytes was carried out 
overnight with aliquots of the cell medium derived from the infected 293T cells 
containing the lentivirus (53RPK PGK GFP). On the following day, infected 
adipocytes were washed with pre-warmed PBS and maintained in adipogenic 
differentiation medium with 3% FBS until the experiments were performed. 
4.6.3 Microscopy 
Transduction efficiency was visualized by fluorescence microscopy (Olympus IX 50). 
The microscope was equipped with an Olympus U-TVO 5XC camera. 
4.6.4 Luciferase assays 
Luciferase activity in transfected cells was measured using Bright-GloTM Luciferase 
Assay System (Promega Corp., Madison, WI, USA), according to the manufacturers 
protocol. Briefly, transfected cells growing in 12-well plates were removed from the 
incubator and the culture medium was aspirated. 100 µl of new cell culture medium 
and 100 µl of reagent were added to each well. Cells were incubated for at least 2 min 
to allow complete cell lysis and the supernatant was transferred into white 96-well 
plates (OptiPlateTM-96, PerkinElmer). Luciferase activity was measured in a plate- 
reading luminometer. 
 
4.7 Protein measurements 
Adipocytes were incubated for 24 h with different treatments. Supernatants were 
collected. For CT peptides, they were concentrated in vacuo at room temperature for 4 
h and then kept on -20°C until analyzed. IL-6 supernatants were collected and diluted 
1:20. 
4.7.1 Immunoluminometric Assay (ILMA)  
Procalcitonin concentrations were determined in supernatants by an ultrasensitive 
chemiluminometric assay (B.R.A.H.M.S PCT sensitive LIA assay) with a functional 
sensitivity of 6 pg/ml (Brahms, Hennigsdorf, Germany) following the manufacturers 
protocol. 
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4.7.2 Radioimmuno Assay (RIA) 
ADM and CGRP concentrations were determined in supernatants by human-specific 
radioimmunoassay kits (Phoenix Europe GmbH, Karlsruhe, Germany) following the 
manufacturers protocol. The analytical sensitivity of the ADM assay was given at 4.3 
pg/tube and that of the CGRP assay at 3.8 pg/tube. 
4.7.3 Enzyme-linked immunoassay (ELISA)  
IL-6 concentrations were determined in supernatants by a human IL-6 immunoassay 
(Quantikine, R&D Systems Europe, Ltd., Abingdon, UK) following the 
manufacturers instructions.  
 
4.8 cAMP concentration measurement 
cAMP concentration was measured using the cAMP-GloTM Assay (Promega Corp., 
Madison, WI, USA) following the manufacturers instructions. Briefly, adipocytes 
growing in 24-well plates were exposed to appropriate stimuli for 1 h followed by 
washing them twice with PBS. 50 µl of lysis buffer were added to each well, cells 
were scraped and incubated for 15 min with shaking. 20 µl of the lysate were 
transferred to a white 96-well plate (OptiPlateTM-96, PerkinElmer). 40 µl of the 
detection solution containing protein Kinase A were added, the plate mixed for 30-60 
sec and incubated for 20 min. 80 µl of the Kinase Glo®-reagent were added, the plate 
mixed for 30-60 sec followed by incubation for 10 min. Luminescence was measured 
using a plate-reading luminometer. 
 
4.9 Adipocyte lysates 
Following stimulation, adipocytes were washed with PBS. Cells were harvested in a 
10 mM Tris-HCl (pH 7.4) lysis buffer containing 1% Triton-100, 0.5% Nonidet P-40, 
protease inhibitors cocktail (Roche Diagnostics, Rotkreuz, Switzerland) and HaltTM 
phosphatase inhibitor cocktail (Thermo scientific, Wohlen, Switzerland) and 
incubated on ice for 10 min. Cell lysates were cleared by centrifugation (10,000 × g, 
10 min). 
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4.10 Western blot analysis 
Protein concentrations of lysates were determined with the DC protein assay kit from 
Bio-Rad (Biorad, Reinach, Switzerland). Reading of the protein concentrations was 
performed in 96-well plates using the SpectraMax 190 microplate reader (Molecular 
Devices, Inc.). Lysates containing equal amounts of proteins (20 µg/sample) were 
boiled for 5 min at 95°C in 1 x Lämmli sample buffer, subjected to 10 % SDS-PAGE 
minigel (both from Bio-Rad) and blotted on a nitrocellulose membrane. After 
blocking of the membrane (1 h, RT in blocking buffer), the membrane was incubated 
overnight at 4°C with primary antibody diluted 1:500, washed and incubated with 
horseradish peroxidase-conjugated goat anti-mouse or anti-rabbit antibodies (45 min, 
RT). Washing steps were carried out in tris-buffered saline containing 0.1% Tween 20 
(Bio-Rad). The Western lightning enhanced chemiluminescence substrate (Perkin 
Elmer) was used for detection on a Medical X-Ray film (Kodak). Membranes were 
stripped in stripping buffer 2 times 5-10 min, washed 2 times for 10 min in PBS and 
for 5 min in TBST before blocking and then reprobed with anti-tubulin antibody as a 
control for equal loading. 
 
4.11 Statistical analysis 
Data represent means ± standard error of the means (s.e.m.) from a minimum of three 
independent experiments, each done in triplicates or from one representative 
experiment out of three. For multigroup comparisons one-way analysis of variance 
was applied with the Bonferroni’s posthoc multiple comparison test. P values < 0.05 
were considered as significant. All analyses were performed using Prism 4.0 
(GraphPad, San Diego, CA). 
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5. Results 
Human preadipocyte-derived adipocytes were used as a model to study the regulation 
of extrathyroidal CALC gene expression. MSC-derived adipocytes were only used for 
lentiviral transfection experiments. 
 
5.1 Differentiation efficiency of preadipocyte-derived adipocytes in 
our human cell culture model  
 
Our preadipocyte-derived adipocyte model is a heterogeneous cell population 
whereby even under optimal conditions the differentiation efficiency from 
preadipocytes to adipocytes is incomplete. In order to evaluate the differentiation 
capacity of preadipocytes and to distinguish undifferentiated preadipocytes from fully 
differentiated adipocytes, our cells were stained with a bodipy dye specific for cellular 
lipid droplets and analysed by flow cytometry. The percentage of bodipy positive cells 
was compared to bodipy negative cells in three independent experiments with cells 
from the same donor but different cell passages.  60.9±3.8 % of the total cells in 
culture were identified as bodipy positive mature adipocytes, 31.2±3.2 % were 
identified as bodipy negative preadipocytes and the remaining 7.8±2.7 % of  bodipy 
negative cells were identified as a third  population and considered as debris from 
cells which died during the culture process (Figure 8). 
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Figure 8: Cell populations in our preadipocyte-derived adipocyte cell culture model 
after 14 days of differentiation. (a) Three different cell populations determined by flow 
cytometry analysis after bodipy 493/503 staining from a total of 25000 cells. Section on the 
left hand side represents cell debris (4.89%), section in the middle the undifferentiated 
preadipocytes (32.1%) and section on the right hand side mature adipocytes (62.4%). Data 
obtained from one representative flow cytometry chart out of 9 analyses showing the number 
of cells according to the log of the bodipy concentration. (b) Percentage of cells per cell 
population represented by the mean ± standard deviation of 9 samples from 3 independent 
experiments. The closed bar represents cell debris, the shaded bar the undifferentiated 
preadipocytes (bodipy negative cell population) and the open bar the mature adipocytes 
(bodipy positive cell population). 
a 
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5.2 Effects of bacterial infection and inflammation on preadipocyte-
derived adipocytes 
5.2.1 Different doses of LPS do not affect cell viability 
The term endotoxin came from the discovery that portions of gram-negative bacteria 
itself can cause toxicity, whereby the toxic effects of endotoxin have been shown to 
be due to LPS. To determine whether administration of LPS has an effect on the cell 
viability of preadipocytes and preadipocyte-derived adipocytes, cells were treated 
with 10ng/ml, 100ng/ml and 1µg/ml of LPS. After 24 hours of incubation, cells were 
stained with bodipy 493/503 and propidium iodide (PI) and analyzed by flow 
cytometry. The percentage of mature preadipocytes and preadipocyte-derived 
adipocytes was not affected compared to untreated cells in our cell cultures after 
exposure to LPS for 24 hours (Figure 9 a). Administration of different doses of LPS 
for 24 hours was only altering slightly the cell viability compared to control (p=n.s.) 
(Figure 9 b).  
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Figure 9. Percentage of differentiated and dead cells after 24h incubation with different 
doses of LPS. (a) Percentage of mature adipocytes (open bars), preadipocytes (shaded bars) 
and debris (closed bars) untreated (control) and after exposure to 10ng/ml, 100ng/ml and 
1µg/ml LPS for 24 hours and staining with bodipy. (b) Percentage of dead cells after 
administration of 10ng/ml, 100ng/ml and 1µg/ml LPS (p=n.s. vs.control) and staining with PI 
followed by flow cytometry analysis. 
5.2.2 Variations in LPS-induced CALC-I gene expression 
The preadipocyte-derived adipocytes for our experiments were gained from 
subcutaneous fat tissue from different donors. To isolate the stromal vascular cell 
fraction containing preadipocytes, we used fat tissue samples from patients who 
differed in criteria such as sex, age, BMI, state of health and medication. The 
preadipocyte-derived adipocytes were differentiated in vitro into mature adipocytes 
and passaged several times for performing experiments. Additionally, stocks of cells 
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at different passages were kept frozen in liquid nitrogen for several months and then 
thawed for further passaging and performing experiments. As assessed by real-time 
PCR, the expression level of CALC-I gene mRNA induced by 100ng/ml LPS varied 
among the different experiments depending on the cell donor and cell passage used. In 
adipocytes derived from different donors a considerable variation in the fold of 
increase in LPS-induced CT or CGRP-I mRNA was measured which was in a range 
from 35 fold to no increase at all compared to control (Figure 10).  
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Figure 10: CT and CGRP-I mRNA expression upon LPS stimulation in human 
adipocytes derived from different donors. Preadipocyte-derived adipocytes from different 
donors and different passages (P) in cell cultures were treated with 100ng/ml LPS for 24 h 
(shaded bars) and compared to untreated cells (open bars) from the same donor or passage, 
respectively. mRNA expression of CT (a) and CGRP-I (b) was analysed by quantitative real-
time PCR. Data are means ± SEM given as ratio vs. housekeeping gene hypoxanthine 
phosphoribosyltransferase (HPRT).  
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5.2.3 LPS induces IL-6 and CALC-I gene mRNA expression in human 
adipocytes 
LPS induced a dose-dependent increase in the mRNA expression level of the pro-
inflammatory cytokine IL-6 (Figure 11 a), indicating that LPS provokes an 
inflammatory response in our adipocyte model. Administration of LPS was also 
leading to an increase in the mRNA level of CT and CGRP-I (Figure 11 b and c). As 
opposed to the case with IL-6, the increase in CALC-I gene mRNA was not dose-
dependent in the chosen dose-range and peaked at a dose of 100ng/ml. 
Figure 11: IL-6, CALC-I and CALC-V gene expression upon LPS stimulation in human 
adipocytes. Preadipocyte-derived adipocytes were treated with 10ng/ml, 100ng/ml and 
1µg/ml LPS for 24 h. mRNA expression of IL-6, (a), CT (b) and CGRP-I (c) was analysed by 
quantitative real-time PCR. Data are means ± SEM of one representative experiment out of at 
least three given as ratio vs. HPRT (*, p < 0.05 vs. control; **, p < 0.01 vs. control; 
***, p < 0.001 vs. control).  
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5.2.4 LPS-induced CALC-I gene expression is independent from NFκB pathway  
The main target receptor for LPS is known to be TLR4 and human adipocytes have 
been shown to express this receptor (57). Since we find an increase in the mRNA 
expression of CT and CGRP-I conjointly with an increase in IL-6 mRNA, we 
investigated whether an inhibitor of the NFκB pathway might block the LPS-mediated 
CALC-I gene activity. As expected, attenuating the activity of NFκB by inhibiting the 
inhibitor of NFκB kinase subunit beta (IKK2) reduced the LPS-induced IL-6 mRNA 
expression. In contrast, the LPS-mediated CALC-I gene mRNA expression was 
increased by this inhibitor (Figure 12).  
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Figure 12: Effect of IKK2 inhibitor on LPS-induced IL-6, CT and CGRP-I gene 
expression in human adipocytes. Preadipocyte-derived adipocytes were untreated (control; 
white bars) or treated with 100ng/ml LPS for 24 h (grey bars) in the presence (shaded bars) or 
absence (open bars) of the IKK2 inhibitor SC-514 (100µM, 24 h). mRNA expression of IL-6 
(upper panel left graph), CT (upper panel right graph) and CGRP-I (lower panel) was 
analysed by quantitative real-time PCR.  
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Whereas the IL-6 mRNA expression was reduced dose-dependently by the IKK2 
inhibitor, CT and CGRP-I mRNA expression showed no dose-dependent increase 
(data not shown). Similarly, co-treatment of LPS-stimulated cells with pyrrodine 
dithiocarbamate (PDTC), a different inhibitor of NFκB, was leading to a decrease in 
IL-6 and to an increase in CALC-I mRNA expression (data not shown). 
 
5.2.5 IL-1β and CALC-I gene expression 
 
IL-1β is one of the prototypic early cytokines induced by LPS as inflammatory 
response to the bacterial infection. Exposure of preadipocyte-derived adipocytes to 
100ng/ml of LPS for 24 hours induced an increase in IL-1β mRNA expression 
(Figure 13).  
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Figure 13: IL-1β expression upon LPS stimulation in human adipocytes. Preadipocyte-
derived adipocytes were treated with 100ng/ml LPS for 24 h. mRNA expression of IL-1β was 
analysed by quantitative real-time PCR. (***, p < 0.001 vs. control).  
 
 
When preadipocyte derived adipocytes were treated with different doses of IL-1β 
(20IU, 2IU and 0.2IU), only the highest dose of 20IU was sufficient to increase the 
expression level of CT (Figure 14 a) and CGRP-I gene mRNA (Figure 14 b).  
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Figure 14: CT and CGRP-I gene expression upon IL-1β stimulation in human 
adipocytes. Preadipocyte-derived adipocytes were treated with 20IU, 2IU and 0.2IU IL-1β 
for 24 h. mRNA expression of CT (a) and CGRP-I (b) was analysed by quantitative real-time 
PCR (**, p < 0.01 vs. control).  
 
5.2.6 Effect of IL-1RA on LPS-induced CALC-I gene expression 
Next we aimed to clarify whether the effect of LPS on the increase in CALC-I gene 
expression is IL-1β-mediated as part of the inflammatory response. Therefore, 
adipocytes were treated with IL-1β and LPS in the presence or absence of the IL-1 
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receptor antagonist IL-1RA. IL-1RA is an agent that binds to the same receptor on the 
cell surface as IL-1, and thus prevents IL-1 binding and signaling. 
Addition of IL-1RA blocked the IL-1β-induced CALC-I gene expression but this 
inhibitor did not prevent the increase in mRNA expression induced by LPS (Figure 
15).  
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Figure 15: Effect of IL-1RA on IL-1β- and LPS-induced CALC-I gene expression in 
human adipocytes. Preadipocyte-derived adipocytes were treated with 20IU IL-1β and 
100ng/ml LPS for 24 h in the presence (shaded bars) or absence (open bars) of IL-1RA 
(20ng/ml, 24 h) and mRNA expression of CT (a) and CGRP-I (b) was analysed by 
quantitative real-time PCR. Data are means ± SEM of three independent experiments as ratio 
vs. HPRT. 
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5.3 Effects of ionomycin and LPS on intracellular calcium 
concentration in human preadipocyte-derived adipocytes 
5.3.1 Effect of ionomycin on cell viability 
Since Ca2+ has been shown to regulate the expression of the CALC gene in cells of 
thyroidal origin such as TT cells (83) it is tempting to speculate that the extrathyroidal 
CALC-I gene expression in human adipocytes is Ca2+ dependent. Methodologically, we 
used 1µM ionomycin as positive control in order to establish the method of measuring 
[Ca2+]i changes in our adipocyte cell model. Ionomycin is an ionophore produced by 
the bacterium Streptomyces conglobulatus and is used to raise the intracellular level 
of calcium by facilitating the transport of Ca2+ ions through biological membranes. 
Potential cytotoxicyty of ionomycin in adipocytes was examined. Cells were treated 
with 1µM ionomycin for 3 or 24 hours in the presence or absence of LPS (100ng/ml 
for 24 hours) and with 10µM ionomycin for 24 hours alone or in combination with 
LPS. After incubation, the cells were stained with bodipy 493/503 and PI and 
analyzed by flow cytometry. 
Neither 1µM ionomycin alone for 3 or 24 hours nor in combination with LPS was 
leading to an increased percentage of dead cells. Only in the cell population incubated 
with 10µM ionomycin the amount of dead cells tended to increas (p=n.s.) (Figure 16 
a). After bodipy staining we found that the cytotoxic effect of 10µM ionomycin after 
24 hours seems to be restricted to mature adipocytes. The percentage of 
undifferentiated adipocytes remained unaffected compared to the decreased 
percentage of differentiated cells and the increase in cell debris (Figure 16 b). 
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Figure 16: Percentage of cells in our cultures after incubation with ionomycin alone or 
in combination with LPS. (a) Administration of 1µM (for 3 or 24 hours) or 10µM 
ionomycin (iono) for 24 h in absence (no LPS) or presence of 100ng/ml LPS for 24 h (+LPS 
for 24h) led to a slight increase of dead cells (p=n.s.), the most dead cells were detected when 
cells were incubated with 10µM ionomycin (b) Percentage of PI negative cells were classified 
into undifferentiated preadipocytes, mature adipocytes and cell debris. Red circles show the 
notable difference in percentage of cells after treatments. Results represent the mean ± SEM 
from 3 independent experiments. 
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5.3.2 Effect of ionomycin on intracellular calcium concentration changes 
Cells were loaded with Fluo-3 AM, which is a high affinity Ca2+ indicator, and 
changes in [Ca2+]i upon ionomycin were visualized by confocal microscopy. When 
Ca2+ is binding to Fluo-3, the fluorescence of the dye is increasing when excited at 
488 nm. Exposure of adipocytes to 1µM ionomycin led to a quick and transient 
increase in [Ca2+]i in the majority of preadipocyte-derived adipocytes (Figure 17). 
However, some adipocytes showed no increase in [Ca2+]i in response to the ionophor 
(i.e. yellow curve). The duration of elevated intracellular calcium varied among every 
cell. The increase in [Ca2+]i lasted from approximately 5 minutes (i.e. dark blue curve) 
until up to 15 minutes  (i.e. pink curve).  
 
 
 
 
Figure 17: [Ca2+]i rises induced by ionomycin in preadipocyte-derived adipocytes loaded 
with Flou-3. Fluo-3 loaded adipocytes were monitored for changes in [Ca2+]i by confocal 
microscopy for about 30 minutes after addition of 1µM ionomycin. Each curve (red, pink, 
light blue, green, dark blue and yellow) represents the fluorescence intensity of Ca2+-bound 
Fluo-3 from an individual cell. 
 
Same as Fluo-3, Fura-2 is a fluorescent Ca2+ indicator but with a different excitation 
wavelength, namely 340 nm when bound to Ca2+ 365 nm when not bound to Ca2+.  
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With our available technical setup we used the excitation wavelength of 405 nm, 
which enabled us to follow changes in the fluorescence of Ca2+-unbound dye, 
resulting in indirect measurement of increased [Ca2+]i . In cells loaded with Fura-2 we 
monitored a decrease in signal intensity in adipocytes upon administration of 
ionomycin. The rather stable signal in fluorescent intensity in cells without the 
characteristic adipocytes phenotype indicates that an ionomycin-induced increase in 
[Ca2+]i  seems to occur more pronounced in mature adipocytes than in undifferentiated 
preadipocytes (Figure 18). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 18: Changes in signal intensity of Ca2+-unbound Fura-2. Time course 
showing signal intensity of Ca2+-unbound dye in the cytoplasm of a mature adipocyte 
(marked with a circle) after administration of 1µM ionomycin pictured with 6 images. 
Every 3 minutes after administration of ionomycin a picture was taken (images 1-6).   
Within the same time period of ionomycin exposure, the signal of Ca2+-unboud dye 
remains much stronger in cells showing a non-adipose phenotype (marked with 
arrows). 
5.3.3 Effect of LPS on intracellular calcium concentration 
Preadipocyte-derived adipocytes have been examined for basal [Ca2+]i  and variations 
upon LPS exposure. Cells were loaded with Fluo-3 AM and excited at 488 nm to 
 1 2 3
4 65
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follow the fluorescent signal of Ca2+- bound Fluo-3. The signal of Ca2+-bound Fluo-3 
increased slowly during the exposure time compared to the signal from untreated 
cells, which even declined (Figure 19 a). One disadvantage of staining the cells with 
fluorescent dyes for live imaging is that the fluorescence fades during the exposure 
time, irrespective of the treatment. 
To validate the results obtained with Fluo-3, we performed experiments with BTC 
AM, an additional fluorescent Ca2+ indicator. Cells were loaded with BTC in the 
absence or presence of LPS and changes in fluorescence intensity were measured 
during 130 minutes after LPS administration.  Excitation at 405 nm shows the 
fluorescence of BTC bound to Ca2+ and excitation at 488 shows the fluorescence of 
Ca2+-unbound dye.  
Some of the cells responded with an increase in [Ca2+]i, whereas for others, no 
response was evident or they only displayed small spontaneous and transient changes 
of [Ca2+]i. But the majority of the cells responding to LPS exhibited a slow and 
sustained increase in [Ca2+]i. In control cells, the fluorescence intensity of both, Ca2+-
unbound and Ca2+-bound BTC declined slightly. In cells treated with LPS the decline 
in the signal intensity of Ca2+-unbound BTC was significantly more pronounced than 
in untreated cells whereas the intensity of the Ca2+-bound BTC declined less 
compared to control or even increased. These findings were considered as indirect 
evidence for increasing [Ca2+]i. Represented by the ratio of Ca2+-bound BTC /Ca2+-
unbound BTC (405nm/488nm), an LPS-induced increase in [Ca2+]i could be observed 
after 90 min (p<0.05 vs. control) and this increase was enhanced thereafter (p<0.001 
vs. control) (Figure 19 b).  
 
Results 
_____________________________________________________________________ 
 56 
0 15 30 45 60 75 90 105 120 135
0
10
20
30
40
50
60
70
80
90
100
110
120
130
140 control
LPS
a
Time (minutes)
Fl
u
o
-
3 
at
 
48
8n
m
 [ar
bi
ta
ry
 
u
n
its
]
0
100
200
300
400
500
600
700
LPS
control
n.s. n.s.
n.s.
n.s.
n.s.
*
**
***
***
n.s.
Time (minutes)
0    15    30    45   60    75    90  105  120  130
b
R
at
io
 
(40
5/
48
8)
[ar
bi
ta
ry
 
u
n
its
]
 
 
Figure 19: [Ca2+]i increase induced by LPS in preadipocyte-derived adipocytes.  
 (a) Representative tracing of [Ca2+]i with Fluo-3 AM in cells that responded to LPS with a 
slow sustained increase. Data are means ± SEM from 5 single cells for control and 5 single 
cells treated with LPS. (b) Increase in intracellular calcium concentration in preadipocyte-
derived adipocytes loaded with BTC AM given as ratio of 405/488 fluorescence from treated 
vs. untreated cells at certain time points after LPS addition. Data are expressed by means ± 
SEM (n=22 single cells from three independent experiments; *, p < 0.05 vs. control; 
**, p < 0.01 vs. control; ***, p < 0.001 vs. control; p = n.s., non significant vs. control).   
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Next, in order to clarify whether cells which did not respond with an increase in 
[Ca2+]i upon LPS treatment within 1 hour were not able to raise their [Ca2+]i, 1µM of 
ionomycin was added. Cells previously exposed to LPS responded with a single rapid 
and transient increase in [Ca2+]i , whereas the ionomycin-induced transient in cells not 
exposed to LPS was much smaller in amplitude and with a slower onset (Figure 20). 
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Figure 20: [Ca2+]i increase induced by ionomycin in preadipocyte-derived 
adipocytes exposed to LPS. Fluo-3 loaded adipocytes were monitored for [Ca2+]i as 
described in Materials and Methods. 7 minutes after measurement start, 100ng/ml LPS were 
added to one chamber of the 2-well chamberslide. After 77 minutes, 1µM ionomycin was 
added to both chambers. Data are means ± SEM from 5 single cells for control and 5 single 
cells treated with LPS. 
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5.4 Role of calcium in lipopolysaccharide-induced CALC gene 
expression in human adipocytes 
5.4.1 Effect on LPS-induced CALC-I gene mRNA expression by inhibiting LPS-
induced intracellular calcium increase  
To investigate whether augmented [Ca2+]i might be responsible for the LPS-induced 
increase in CT and CGRP-I mRNA, the cells were treated with different substances 
blocking an increase in [Ca2+]i.  The increase in CT and CGRP-I mRNA expression 
after LPS administration (p<0.001 vs. control) (100 ng/ml for 24 hours) was lowered 
by simultaneous treatment with 20µM of verapamil, a Ca2+ ion flux inhibitor, 
preventing Ca2+ influx from the extracellular space (p<0.05 for CT and p<0.01 for 
CGRP-I vs. LPS). Addition of verapamil to cells treated with LPS also led to a 
reduced mRNA expression level of IL-6, but in a much lower extent than for CT and 
CGRP-I (p=n.s. vs. LPS) (Fig. 21 a). 
When cells were co-treated with 20µM of 2-APB, an ionositol triphosphate (IP3) 
receptor antagonist which inhibits store operated calcium release, the LPS induced 
CALC-I mRNA expression level was blocked almost down to control level (p<0.001 
vs. LPS). Same as for verapamil, addition of 2-APB in cells exposed to LPS only led 
to a slight reduction of IL-6 mRNA expression in a much lower extent than for CT 
and CGRP-I (p=n.s. vs. LPS) (Fig. 21 b). 
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Figure 21: Impact of reduced intracellular calcium concentration on LPS- induced 
CALC-I gene and IL-6 mRNA expression in human adipocytes.  (a) Preadipocyte-derived 
adipocytes were treated with 100ng/ml LPS for 24 h without (open bars) or with (closed bars) 
addition of 20µM of verapamil. mRNA expression for CT (upper panel), CGRP-I (middle 
panel) and  IL-6 (lower panel) was analysed by quantitative real-time PCR. (b) Cells were 
treated with 100ng/ml LPS for 24 h without (open bars) or with (closed bars) addition of 
20µM of 2-APB.  mRNA expression of CT (upper panel), CGRP-I (middle panel) and  IL-6 
(lower panel) was analysed by quantitative real-time PCR. Data are means ± SEM of three 
independent experiments given as ratio vs. HPRT (*, p < 0.05 vs. control; **, p < 0.01 vs. 
control;***, p < 0.001 vs. control; p = n.s., non significant vs. control).  
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5.4.2 Effects of intracellular calcium increase on LPS-induced CALC-I gene and 
IL-6 expression 
We examined the effect of increased [Ca2+]i on LPS-induced CALC-I gene induction. 
Therefore cells were treated with 1µM ionomycin for different time spans from 3 to 
24 hours. The duration of incubation with ionomycin did not influence its effects (data 
not shown). The CT and CGRP-I mRNA expression level upon ionomycin treatment 
was comparable with the increase after LPS treatment alone. IL-6 mRNA expression 
also increased with ionomycin administration. Addition of ionomycin in an 
inflammatory background, namely in cells co-treated with LPS for 24 hours, 
potentiated the increase in CT and CGRP-I mRNA expression (p<0.001 for CT and 
p<0.01 for CGRP-I vs. control, LPS and ionomycin alone). When LPS and ionomycin 
were combined, the IL-6 mRNA expression level also went up, but more in an 
additive manner and to a much lower extent than that of the mRNA of CT and CGRP-
I (p<0.001 vs. control and p<0.01 vs. LPS alone) (Fig. 22 a). The increment of Ca2+ 
and LPS-induced CT, CGRP-I and IL-6 mRNA expression was reproduced when the 
cells were preincubated with thapsigargin (100nM, for 1 h). Thapsigargin acts as an 
endoplasmatic reticulum Ca2+ ATPase inhibitor, leading to [Ca2+]i elevation from an 
intracellular store source (p<0.001 vs. control, LPS and thapsigargin alone) (Fig. 22 
b). 
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Figure 22: Impact of increased intracellular calcium concentration on LPS- induced 
CALC-I gene and IL-6 mRNA expression in human adipocytes.  (a) Preadipocyte-derived 
adipocytes were treated with 100ng/ml LPS for 24 h, with 1µM of ionomycin for 3h or 24h or 
with LPS and ionomycin in combination. mRNA expression for CT (upper panel), CGRP-I 
(middle panel) and  IL-6 (lower panel) was analysed by quantitative real-time PCR. (b) 
Adipocytes were treated with 100ng/ml LPS for 24 h, with 100nM of thapsigargin for 24h or 
with LPS and thapsigargin in combination after 1 h of pretreatment with thapsigargin. mRNA 
expression for CT (upper panel), CGRP-I (middle panel) and  IL-6 (lower panel) was 
analysed by quantitative real-time PCR. Data are means ± SEM of three independent 
experiments given as ratio vs. HPRT (**, p < 0.01 vs. control; ***, p < 0.001 vs. control). 
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5.4.3 Effects of altering calcium concentration on CT peptide and IL-6 secretion 
When [Ca2+]i was increased by ionomycin in conjunction with LPS, we measured the 
secretion of ProCT (p<0.001 vs. control), CGRP-I (p<0.01 vs. control) and IL-6 
(p<0.001 vs. control) protein into the supernatant. Similar to the mRNA expression 
level, the amount of protein was reduced when Ca2+ influx from the extracellular 
space was prevented by addition of verapamil (p<0.01 for ProCT and p<0.05 for 
CGRP-I). In contrast, the LPS/ionomycin-induced IL-6 protein secretion was only 
slightly reduced in the presence of verapamil (p=n.s.) (Fig.  23). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 23: Protein secretion of ProCT, CGRP and IL-6 after altering intracellular 
calcium concentrations. After treatments for 24 hours with LPS and ionomycin without 
(open bar) or with (closed bar) the addition of verapamil, release of corresponding peptides 
into the supernatant was determined by supersensitive chemiluminometric assay (ProCT) 
(upper panel left), RIA (CGRP) (upper panel right) or ELISA (IL-6) (lower panel) 
(*, p < 0.05; **, p < 0.01; ***, p < 0.001; p = n.s., non significant). 
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5.4.4 Effects of intracellular calcium concentration changes on LPS-induced 
CALC-V gene expression 
Administration of 100 ng/ml LPS to the adipocytes for 24 hours tended to reduce 
CALC-V gene expression as assessed by ADM mRNA expression (p=n.s.). 1µM 
ionomycin for 3 to 24 hours decreased ADM mRNA expression in both untreated and 
LPS treated cells (p<0.001 vs. control). The decrease of ADM mRNA expression with 
elevated [Ca2+]i was reproduced when the cells were treated with 100nM of 
thapsigargin alone or in combination with LPS (p<0.001 vs. control) (Fig. 24 a). 
Addition of verapamil had no effect on mRNA expression of ADM on cells treated 
with LPS, ionomycin or their combination (p=n.s.) (Fig. 24 b) and preventing the 
efflux from intracellular stores by addition of 2-APB did not affect mRNA expression 
of ADM (p=n.s.) (Fig. 24 c). ADM protein secretion into the supernatant was not 
altered by treatment with LPS or verapamil and neither by their combination, whereby 
ionomycin alone or in combination with LPS lead to a profound decrease in ADM 
secretion (p<0.01 and p<0.05 vs. control) (Fig.24 d). 
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Figure 24: Alterations in intracellular calcium concentration on LPS- induced CALC-V 
gene mRNA expression in human adipocytes.  (a) Preadipocyte-derived adipocytes were 
treated with 100ng/ml of LPS for 24 h, with 1µM of ionomycin for 3 h or 24 h or with 100nM 
thapsigargin for 24 h. mRNA expression for the CALC-V gene adrenomedullin (ADM) was 
analysed by quantitative real-time PCR. (b) Preadipocyte-derived adipocytes were treated 
with with 100ng/ml of LPS, 1µM of ionomycin or their combination for 24 h without (open 
bars) or with (closed bars) addition of 20µM of verapamil. mRNA expression for ADM was 
analysed by quantitative real-time PCR. (c) Cells were treated with LPS for 24 h without 
(open bar) or with (closed bar) addition of 20 µM of 2-APB. mRNA expression for ADM was 
analysed by quantitative real-time PCR.  (d) After treatments with 100ng/ml of LPS, 1µM of 
ionomycin or their combination for 24 h without (open bar) or with (closed bar) 20µM 
verapamil addition, release of ADM peptide into the supernatant was determined by RIA.  
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5.5 CALC-I gene promoter activity upon increased Ca2+ 
5.5.1 Stable transfection of CALC-I gene promoter deletion constructs 
Bacterial induced CALC-I gene expression on the transcriptional level was examined 
by a lentiviral bidirectional vector system. This system is able to amplify 
simultaneously the expression of both, the target gene (CALC-I gene promoter 
connected to luciferase) and a reporter gene (GFP) using two independent promoters. 
The benefit of this vector is to ensure that every cell expressing GFP contains also a 
CALC-I gene promoter construct. To find the part on the promoter responsible for 
infection-induced CALC-I expression, five different CALC-I gene promoter deletion 
constructs were used for transfection (Figure 25). 
 
 
a 
 
 
 
 
 
 
 
 
b  
 
 
 
 
 
 
 
 
 
 
Figure 25: CALC-I gene promoter deletion constructs. (a) Bidirectional lentiviral system 
expressing the two genes green fluorescent protein (GFP) and Luciferase (luc+) at the same 
time under the control of two separate promoters. The bidirectional vector 53RPA-PGK-GFP 
expressed GFP under the PGK promoter for normalization of transduction efficacy (b) 
Schematic representation of the 5’ deletions (hCTPro1705, hCTPro1376, hCTPro1033, 
hCTPro516, hCTPro149) in the promoter region of the human CT gene. ‘hCTPro’ indicates 
‘human CT promoter’ and the number behind for the amount of base pairs from the 
transcriptional start site of the gene. 
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The lentiviral vectors containing the five different CALC-I gene promoter constructs 
were stably transfected into TT cells and into human MSC- derived adipocytes. The 
TT cells were used as positive control for successful virus generation and transfection. 
GFP activity in TT cells was observed 2 days and in adipocytes 5 days post 
transfection by fluorescence microscopy. Figure 26 a displays the mature adipocytes 
transiently transfected with the different promoter deletion constructs. As assessed by 
Flow cytometry analysis (data not shown), the transfection efficacy in adipocytes of 
the different constructs was only below 10%. The more base pairs the promoter 
construct contained, the lesser was the transfection efficiency. This phenomenon 
could be observed in TT cells, where less GFP positive cells were detected in cells 
transfected with hCTPro1705 than with hCTPro149 (Figure 26 b) and also in 
adipocytes. Accordingly, the activity of the hCTPro149 construct was about 5 times 
higher than that of the hCTPro516 and even around 100 times higher than that of the 
hCTPro1705 construct at basal conditions (Figure 26 c). 
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Figure 26: Transduction of human MSC- derived adipocytes. a) Mature human MSC-
derived adipocytes were exposed to different lentiviral vectors containing the CALC-I gene 
promoter deletion constructs and GFP under a PGK promoter (53RPA PGK GFP). The 
pictures were taken with the Olympus IX 50 fluorescent microscope 5 days after transduction. 
b) TT cells transfected with the empty vector, the shortest CALC-I gene promoter deletion 
construct hCTPro149 and the largest construct hCTPro1705. The pictures were taken with the 
Olympus IX 50 fluorescent microscope 2 days after transduction. c) Basal luciferase activity 
of the different transfected hCTPro constructs shown in a).  
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5.5.2. Increased luciferase activity upon ionomycin  
Stimulation of cells with ionomycin at 1µM for 1 hour, increased the activity of 
hCTPro516, hCTPro1033, hCTPro1376 and hCTPro1705. The ionophore effect was 
not observed with hCTPro149 and the empty control vector (Figure 27).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 27: Luciferase activity upon ionomycin in MSC-derived adipocytes transfected 
with lentiviral constructs containing different CALC-I gene promoter deletion 
constructs. Cells were stimulated with none or 1µM ionomycin for 24 hours. The results are 
expressed as percentage of luciferase activity relative to that of the corresponding hCTPro 
construct under basal conditions. 
 
When tranfected adipocytes were stimulated with LPS for 24 hours, we could not 
observe any consistent results concerning differences in the luciferase activity as 
compared to basal. 
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5.6 Expression of DREAM in human preadipocytes and adipocytes  
We examined whether the Ca2+-dependent transcriptional regulator DREAM is 
expressed in the preadipocytes and adipocytes of our cell cultures. Figure 28 shows 
the result of Western blotting using an anti-DREAM antibody, indicating the presence 
of endogenous DREAM in preadipocytes and in adipocytes after 7 days and 14 days 
of differentiation. TT cells, which are of thyroid origin and known to express 
DREAM (83) were used as positive control. From preadipocytes to mature 
adipocytes, the DREAM protein content increases with advancing differentiation 
state. In parallel, the tubulin protein content decreases in cells undergoing adipose 
differentiation as previously described by Spiegelman and Farmer (115) due to a 
change of cellular structure. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 28: Expression of DREAM. Protein from whole lysate was extracted from 
preadipocytes and adipocytes after 7 days and after 14 days of differentiation. Western 
blotting (20 µg of protein extract/sample) with anti-DREAM antibody shows the expression 
of DREAM in preadipocytes and adipocytes in both differentiation stages. TT cell protein 
extract was also analyzed as a positive control. For the loading control of protein the 
expression of tubulin is shown. 
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sequence exists in the promoter region between basepair 149 and 516 provides a 
rationale to further investigate the impact of Ca2+ on CT expression via DREAM. 
 
5.7 Effects of cAMP on LPS-induced CALC-gene expression in 
preadipocyte-derived adipocytes 
5.7.1 Increase in CALC-I gene mRNA expression with forskolin 
cAMP is an important second messangers activating numerous other enzymes 
involved in diverse cellular functions. In order to assess if increased cAMP levels also 
alter LPS-induced CALC gene expression, preadipocyte-derived adipocytes were 
exposed to forskolin in the presence or absence of LPS and changes in CALC gene 
and IL-6 mRNA levels were measured.  Forskolin acts primarily as a direct activator 
of the adenylat cyclase, which results in increased cAMP in cells. 
Forskolin strongly increased the mRNA expression of CT and CGRP-I and decreased 
the mRNA expression level of ADM. Basal mRNA expression of IL-6 was also 
increased slightly by foskolin. LPS in combination with forskolin did not alter the 
forskolin effect on CT and ADM mRNA expression (p=n.s.) but led to an increased 
expression of forskolin-induced IL-6 and CGRP-I mRNA level (p<0.001) (Figure 
29). 
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Figure 29: Changes in mRNA expression level of CALC-I, CALC-V and IL-6 induced 
by forskolin in preadipocyte-derived adipocytes in presence or absence of LPS. 
Adipocytes were exposed to 1µM forskolin (shaded bars) for 24 hours in the presence (grey 
bars) or absence (open bars) of LPS and assessed for changes in mRNA expression for CT, 
CGRP-I, ADM and IL-6 by real-time PCR. Data are means ± SEM of three independent 
experiments given as ratio vs. HPRT (***, p < 0.001 vs. no LPS; p=n.s. or not statistically 
significant vs. no LPS). 
 
5.7.2 Effects of LPS and IL-1β on cAMP levels in adipocytes 
Since increased cAMP has been shown to have an impact on CALC gene expression, 
we determined the effect of LPS and IL-1β on cAMP levels within the cell. 
Preadipocyte-derived adipocytes were treated with 100ng/ml LPS, 20IU/ml IL-1β and 
their combination and the cAMP concentrations were measured after 1 hour of 
incubation. Exposure to LPS showed no effect on the cAMP level, but 1 hour after IL-
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1β administration we measured an increased level in cAMP concentration, 
comparable to the increase caused by forskolin. In contrast, elevated [Ca2+]i caused by 
ionomycin did not lead to an increase of cAMP within 1 hour (Figure 30). 
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Figure 30: cAMP concentration level in preadipocyte-derived adipocytes. The 
concentration of cAMP are presented in adipocytes exposed to 100ng/ml LPS, 20IU/ml IL-1β, 
both together, 1µM forskolin and 1µM ionomycin for 1hour. 
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6. Discussion 
 
Despite the substantial investment in critical care resources, bacterial infections and 
sepsis remain a major threat with a high morbidity and mortality. The host response to 
bacterial infection involves the activation of complex immune mechanisms and the 
release of a wide array of inflammatory mediators (116).  
Expression levels of CT peptides, mainly of the CT precursor peptide ProCT increase 
ubiquitously, whereby the major source for CT peptide expression arises from 
parenchymal cells. As human adipose tissue and adipocytes themselves contribute to 
infection-and inflammation-induced CT peptide expression, we aimed to study the 
regulation of extrathyroidal CT peptide expression in a human preadipocyte-derived 
cell culture model. Fat tissue samples of different donors rather than neoplastic cell 
cultures were chosen, to bear more upon physiological conditions. 
 
Human preadipocyte-derived adipocytes serve as a suitable model to study LPS-
induced CALC gene expression 
First, we characterised and validated the suitability of our human preadipocyte-
derived adipocytes model to study in vitro the effect of LPS on the expression of the 
CALC genes and thereby gain insight into potential regulatory mechanisms. 
Adult human adipose tissue has been reported to be composed of 50–70% adipocytes, 
20–40% stromal vascular cells such as preadipocytes, fibroblasts and non-
differentiated mesenchymal cells and 1–30% infiltrated macrophages (117). Our 
cultures of in vitro differentiated adipocytes showed no or only negligible amounts of 
macrophage markers (i.e. CD68) and the medium provided to cell cultures favors 
preadipocyte expansion and adipogenesis. Especially, the expression of pro-
inflammatory cytokines has been assigned to preadipocytes rather than to mature 
adipocytes (117, 118). Since our cell model consists of at least two different cell types 
(i.e. preadipocytes and adipocytes) we cannot exclude that preadipocytes do not 
contribute to some effects observed. However, it was demonstrated in previous work 
from our group (28) that the CALC-V gene is only weakly expressed and the CALC-I 
gene is not expressed at all in undifferentiated MSCs upon LPS or LPS in 
combination with inflammatory stimuli. Nevertheless, the definite source of mRNA 
expression and peptide secretion in our cell cultures does not preclude the validity of 
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the experimental evidence gathered, as both, the presence of preadipocytes goes along 
with mature adipocytes in human adipose tissue in vivo.  
Using cells originating from different patients, we almost always observed an increase 
in CALC-I gene expression upon LPS stimulation independent of the donor, but the 
fold of increase varied considerably. While we do not have a final explanation for this 
variability, we suppose a context in inter-individual pheno- and genotypic differences 
of the diverse donors. There were no indications that the sex or the BMI might play a 
role. The latter finding concerning the BMI is so far surprising, as obesity is 
associated with chronic low grade inflammation, which in turn is associated with 
increased levels of ProCT  (119). We found that in cells from one donor suffering 
from pancreatitis, LPS stimulation was leading to a slightly higher CALC-I gene 
expression level compared to others (see Figure 10, donor 2). This anecdotal 
observation indicates that an acute infection in the patient might either influence the 
sensitivity of the preadipocyte-derived adipocytes to LPS stimulation or increase the 
susceptibility of the cells to respond with enhanced CALC-I gene activity. In this 
context, it is mentionable that Ammori et al. described increased levels of calcitonin 
precursors in patients with acute pancreatitis (120). 
In addition to the variability traced back to different donors, mRNA expression levels 
also varied depending on the batch of cells and the cell culture passages used for the 
single experiments. Most likely our cells experience alterations in their response to 
stimuli and their protein expression during passaging. In addition, the time to reach 
confluence and efficient differentiation varied; consequently the total ratio between 
undifferentiated preadipocytes and differentiated adipocytes varied from experiment 
to experiment, even within cells from the same donor and according to the passages. 
However, the tendency toward an increase in LPS- mediated CALC-I gene and IL-6 
expression was consistent within the different experiments. 
The expression of IL-6, CT and CGRP-I seem rather to result from a distinct response 
of intact cells to specific inflammatory pathways activated by LPS and not from a 
simple “toxic” effect. In contrast to previous results from our group shown in MSC-
derived adipocytes, our preadipocyte-derived adipocytes did not react with elevated 
ADM mRNA expression levels or protein release upon LPS exposure for 24 hours. 
Additionally, the expression levels of CT and CGRP-I mRNA in preadipocyte-derived 
adipocytes was in a lower range compared to previous results from adipocytes derived 
from MSCs. These findings indicate that the preadipocyte-derived adipocyte cell 
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culture model cannot be equalled in all aspects with the MSC-derived adipocyte cell 
culture model.  
 
Distinct inflammatory signaling pathways are involved in LPS-induced IL-6 and 
CALC-I gene mRNA expression 
We confirmed that LPS increases the expression of IL-6 in human adipocytes via 
activation of the NFκB pathway (121). When inhibiting the activation of NFκB by 
blocking IKK2, we observed a reduction of IL-6 mRNA expression, contrasting the 
increased expression level of CALC-I gene mRNA. Since high amounts of ProCT and 
CGRP-I have been shown to be unfavorable prognostic findings, this might indicate a 
putative protective function of inflammatory signaling via NFκB in respect to CALC-I 
gene activation.  
LPS uses different receptors and/or signaling pathways in different cell types and there 
are fundamental signaling differences between human and murine macrophages and 
between cells of myeloid and non-myeloid origins (122, 123), respectively. For 
instance IKK2 is not required for LPS-induced NFκB activation and cytokine 
production in human immature dendritic cells (122). LPS might signal via IKK2 in 
preadipocytes but not in adipocytes and, thus, explain the distinct mRNA expression 
pattern for IL-6 and CALC-I gene mRNA upon IKK2 inhibition. Indeed, our cell 
culture model consists of both, preadipocytes and mature adipocytes, whereby the 
expression of CT and CGRP-I is assigned to adipocytes (28, 117) and the pro-
inflammatory response by IL-6 induction is more pronounced in preadipocytes (117).  
 
Role of IL-1β in extrathyroidal CALC-I gene expression  
Besides IL-6 and CALC-I genes, stimulation with LPS induces IL-1β expression in 
different cell types (124, 125). As principal function this cytokine is pro-
inflammatory. In the current work, it was shown that the cells in our cell culture 
model are able to respond to LPS with increased IL-1β expression. Conversely, IL-1β 
itself induced CT gene expression and ProCT secretion in ex-vivo differentiated 
human adipocytes (47) and CGRP-I mRNA and protein secretion in MSC-derived 
adipocytes (28).  These findings raised the question whether the increase in CALC-I 
gene expression mediated by LPS is occurring downstream of LPS via IL-1β. 
Importantly, inhibiting the IL-1 receptor was blocking the expression of IL-1β-
induced CALC-I gene expression but not the expression induced by LPS. 
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Role of calcium in LPS-induced CALC-I gene expression 
Little is known about the role of [Ca2+]i in LPS stimulation in human adipocytes 
whereas in macrophages it has been studied extensively. Even though the consensus 
has been that LPS does not cause an increase in [Ca2+]i but a baseline calcium 
concentration is required for proper cell activation in response to LPS (126), there are 
results with macrophages demonstrating that LPS stimulation increases phosphatidyl 
inositol turnover (127) and increases in [Ca2+]i upon LPS in rat peritoneal 
macrophages have been described (128). In our experimental model, the adipocytes 
were stimulated with either LPS or, as a positive control, ionomycin. In the majority 
of adipocytes, but not in each single cell monitored for changes in [Ca2+]i, ionomycin 
was able to cause an increase in [Ca2+]i. LPS stimulation increased [Ca2+]i, only 
inconsistenly. The fast, massive and transient response in [Ca2+]i increase elicited by 
ionomycin contrasted with the slow, modest but sustained increase induced by LPS. 
The onset and duration of the [Ca2+]i increase caused by either ionomycin or LPS was 
not correlated with a particular morphologic appearance of the adipocyte. Our 
findings on the effect of LPS on [Ca2+]i changes in adipocytes are in line with the 
findings made by Letari et al. where only 47% of  individually observed rat peritoneal 
macrophages responded to LPS exposure with an increase in [Ca2+]i , and for their 
macrophages, same as for our adipocytes, a heterogeneous response was observed 
(128).  
The Ca2+ mobilization observed after LPS exposure was dependent from an influx of 
Ca2+ from the extracellular space and probably a release from intracellular stores 
mediated by IP3, followed by an influx through store-operated channels. Accordingly, 
LPS-induced CALC-I gene expression was reduced after diminishing [Ca2+]i by 
verapamil and 2-APB. On the other hand the LPS-induced CALC-I gene expression is 
potentiated with increasing [Ca2+]i through addition of ionomycin or depletion of 
intracellular Ca2+ stores with thapsigargin.  
Interestingly, the number of adipocytes responding with increased [Ca2+]i upon LPS 
stimulation was markedly higher in cells deriving from donors where the LPS-induced 
CALC-I gene mRNA expression was more pronounced than in cells from donors with 
a low fold of mRNA increase. This observation might pull together a dependence of 
LPS-mediated CALC-I gene expression on increased [Ca2+]i. Moreover we found that 
upon ionomycin, changes in [Ca2+]i and changes in CALC-I gene expression were 
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more pronounced in mature adipocytes than in preadipocytes. The finding that 
adipocytes which did not react with increased [Ca2+]i upon LPS exposure answered 
much faster and with higher amplitude to ionomycin than control cells gives 
additional indication on a putative role of Ca2+ in LPS- induced infection and may 
serve as a link to our results showing how CALC-I gene expression is potentiated in 
the combination of LPS with agents increasing [Ca2+]i. 
Varying intra- and extracellular Ca2+ with Ca2+ agonists and Ca2+ antagonists alters 
cellular production of numerous cytokines including TNF-α, IL-1β, IL-2, IL-8 and IL-
6 (129-133). An increase in [Ca2+]i only triggers cytokine production in conjunction 
with LPS (129, 131). These findings are in accordance with our results showing 
increased expression of CT peptides and IL-6 when treating cells with Ca2+ liberators 
together with LPS. In our adipocyte model, Ca2+ acts at the transcriptional level of the 
LPS-induced CALC genes and IL-6, but presumably with a distinct molecular 
mechanism. Ca2+ seems to have a greater impact on LPS-induced CALC-I gene 
expression than on the one of IL-6. Further investigations are needed to unravel the 
mechanisms through which alterations in [Ca2+]i influence their gene expression. In 
thyroid C cells CT is secreted upon an increase in plasma Ca2+ to reduce the level of 
Ca2+. The increase in Ca2+ probably triggers the activation of Ca2+-sensing receptors 
on the surface membrane of thyroid cells (134), leading to an activation of G-coupled 
signaling pathway to increase intracellular Ca2+(135). Ca2+ then binds to DNA via 
transcriptional cofactors (136) resulting in transcription of CT mRNA (137). Similar 
as for thyroid C-cells, the increased [Ca2+]i might result in activation of Ca2+-regulated 
cofactors on the CALC-I gene promoter in adipocytes, leading to the high rates of 
ProCT and CGRP production in bacterial infection.  
 
Distinct role of calcium in ADM expression 
An additional observation from our study was the distinct modulatory effect of 
increased [Ca2+]i on inflammatory CALC-gene expression. While LPS-mediated 
elevations of [Ca2+]i in an inflammatory background potentiated the activity of the 
CALC-I gene, CALC-V (ADM) gene expression was reduced, both at the mRNA and 
the protein level. Several studies exploring the effect of modulating [Ca2+]i in septic 
patients have been performed with mixed conclusions. In endotoxemia, Ca2+ 
antagonists improved survival in animal models of septic rats and mice (130, 138, 
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139). In contrast, inhibitors of Ca2+ release from intracellular store decreased survival 
in septic rats (140).  
In our study, an increase in [Ca2+]i in human adipocytes led to a decrease in CALC-V 
mRNA expression and protein secretion which was not converted when reducing 
increased [Ca2+]i .Together this might indicate that at an early stage of sepsis an 
elevated [Ca2+]i  might be responsible for the low amount of CALC-V compared to the 
high amount of CALC-I gene expression and that CALC-V gene expression is 
upregulated with progressing course of sepsis. Accordingly, Christ-Crain et al. (45, 
46, 141) reported that proadrenomedullin (ProADM) is a prognostic factor in 
respiratory tract infection and sepsis with high levels indicating poor survival and 
serious adverse events. In contrast, the CALC-I gene product ProCT is more 
diagnostic than prognostic marker indicating the presence of bacterial infection and 
need for antibiotic therapy. The distinct effects of calcium on CALC-V and CALC-I 
transcription and translation could be interpreted as molecular basis for these 
clinically important and distinct characteristics. 
 
Transcriptional regulation of CALC-I gene expression at its promoter level upon 
LPS and calcium 
With the use of lentiviral mediated reporter assays, we aimed to identify putative 
inflammation response elements within the CALC-I gene promoter. To determine 
changes in CALC-I gene promoter activity in adipocytes tranfected with lentiviral 
constructs, luciferase reporter assays were carried out. This technique turned out not 
to be suitable for our adipocyte culture model due to the variability in transduction 
efficiency of the different lentiviral constructs in the cells. When adipocytes 
transfected with the different CALC-I promoter deletion constructs were treated with 
LPS, we had difficulties to obtain consistent results  We ascribed this inconsistency to 
some of the technical problems which might appear when working with cell cultures 
of human mature adipocyte. Adipocytes are spherical and vary in diameter from 10 to 
over 120 pm. They are fragile and possess one unusual biophysical characteristic 
among mammalian cells: they have a specific gravity less than that of water. 
Consequently, they float in commonly used buffers, yielding an unstable output signal 
and making conventional analytical methods difficult (142). For the luciferase assay 
system we were using, the cells were lysed in the cell culture plates and then 
transferred into suitable 96-well plates. Homogenizing the suspension of lysed cells 
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by mixing before transferring them was probably producing severe mechanical 
damages. The transferred suspension was cloudy and sticky due to the lipid contend 
from the fat droplets, which interfered with the assay. The fact that LPS only led to a 
slow and sustained increase in [Ca2+]i and this increase did not occur in all cells 
complicated the experimental settings even more, especially taking into account the 
low transfection efficiency. Nevertheless, in some pilot experiments we repeatedly 
managed to observe that treatment with ionomycin led to increased CALC-I gene 
promoter activity in adipocytes. Our results were in accordance with results from 
Matsuda et al. (83) where the ionomycin-induced increase in luciferase activity was 
starting with the first CALC-I gene promoter deletion construct containing the two 
DRE motifs. Additionally, the fact that preadipocytes and adipocytes were shown to 
express the Ca2+-dependent transcriptional repressor DREAM will encourage us to 
further study Ca2+ as a potential key player in the LPS-induced extrathyroidal CALC 
gene expression. 
 
Involvement of cAMP in extrathyroidal CALC-gene expression 
We found that elevated cAMP concentration levels caused by forskolin alter the 
mRNA expression of the CALC-I and CALC-V gene and of IL-6 in preadipocyte-
derived adipocytes. Similar as observed for Ca2+, increased cAMP levels led to 
increased expression levels of CT and CGRP-I mRNA but to reduced mRNA 
expression levels of ADM. The response in IL-6 mRNA expression to cAMP was 
comparable to the IL-6 mRNA expression response to Ca2+, meaning that the mRNA 
increase triggered by forskolin and LPS alone seemed to increase additively when 
cells were co-treated with both substances. In contrast to Ca2+, an inflammatory 
background caused by LPS did not alter the cAMP-induced expression of CT but 
treatment with forskolin increased CGRP-I mRNA expression in the presence of LPS. 
Albeit to a lesser extent as ProCT, circulating CGRP is elevated in sepsis, namely in 
the protracted and severe phases of septic shock (41, 143,144). The late state of sepsis 
is associated with elevations of intracellular cAMP in Kupffer cells (145). In the 
present work, we found that intracellular cAMP concentrations increase in 
preadipocyte-derived adipocytes within 1 hour after exposure to IL-1β but not after 
exposure to LPS or ionomycin. In contrast, LPS induced increasing
 
levels of [Ca2+]i 
within a comparable time period. As both, LPS and IL-1β have been shown to induce 
expression of CT and CGRP, these findings indicate that Ca2+ and cAMP might both 
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be involved in extrathyroidal CALC gene expression. Both, increases in [Ca2+]i and 
cAMP levels lead to elevated CALC-I gene expression, even if the two CALC-I gene 
splicing products CT and CGPR-I seem not to respond to these two second 
messengers in exactly the same way. It appears that cAMP gets more important at 
later states of sepsis. However, this may not be the case for the CALC-V gene ADM 
which is downregulated with both, [Ca2+]i and cAMP levels but upregulated with 
progressing states of sepsis (141). 
 
Conclusions and outlook 
In conclusion, LPS-and IL-1β induce an upregulation of the pro-inflammatory 
cytokine IL-6 and the CALC-I genes CT and CGRP-I in our cell cultures of 
preadipocyte-derived adipocytes. This is mediated by increased levels of [Ca2+]i and 
cAMP. The LPS-induced IL-6 and CALC-I gene expression seems not to be activated 
via the same signaling pathways. While IL-6 mRNA expression is regulated via the 
classical NFκB pathway, CALC-I gene expression is regulated otherwise. In contrast 
to the upregulation of the CALC-I gene, the CALC-V gene ADM is downregulated 
upon increased levels of [Ca2+]i and cAMP. The molecular mechanism of Ca2+ and 
cAMP mediating the extrathyroidal CALC-I gene expression in infection and 
inflammations remains unknown. However, in view of the presence of the 
transcriptional repressor DREAM in human adipocytes we suggest that Ca2+ and 
cAMP might act on transcriptional level of the CALC-I gene in coherence with DRE-
DREAM and DREAM-CREM/CREB interaction.  Further elucidation of the effect of 
LPS and IL-1β on CALC-I gene expression in respect to DRE-DREAM and 
DREAM-CREM/CREB interactions will help to unravel the mechanism of 
extrathyroidal CALC-I gene expression in bacterial infection and sepsis. 
 
 
References 
_____________________________________________________________________ 
 81 
7. References 
 
1. Becker K.L., Müller B., Nylen E.S., Cohen R., R.H. S 2001 Calcitonin gene 
family of peptides and its receptors. In: Principles and Practice of 
Endocrinology and Metabolism; JB Lippincott Co, Philadelphia, PA, USA. 
3rd ed: Becker K.L. (ed). 520-534 
2. Born W., J.A. F 1993 Calcitonin gene products:molecular biology, 
mechanism, and actions. In: Handb Exp Pharmacol; 569-616 
3. Muff R, Born W, Fischer J 1995 Calcitonin, calcitonin gene-related peptide, 
adrenomedullin and amylin: homologous peptides, separate receptors and 
overlapping biological actions. Eur J Endocrinol 133:17-20 
4. Hutton J, Rhodes C 1991 The enzymology of proinsulin conversion. Cell 
Biophys 19:57-62 
5. Schuetz P, Christ-Crain M, Thomann R, Falconnier C, Wolbers M, 
Widmer I, Neidert S, Fricker T, Blum C, Schild U, Regez K, 
Schoenenberger R, Henzen C, Bregenzer T, Hoess C, Krause M, Bucher 
H, Zimmerli W, Mueller B 2009 Effect of procalcitonin-based guidelines vs 
standard guidelines on antibiotic use in lower respiratory tract infections: the 
ProHOSP randomized controlled trial. JAMA 302:1059-1066 
6. Müller B, Christ-Crain M, Schuetz P 2007 Meta-analysis of procalcitonin 
for sepsis detection. Lancet Infect Dis 7:498-499; author reply 502-493 
7. Briel M, Schuetz P, Mueller B, Young J, Schild U, Nusbaumer C, Périat 
P, Bucher H, Christ-Crain M 2008 Procalcitonin-guided antibiotic use vs a 
standard approach for acute respiratory tract infections in primary care. Arch 
Intern Med 168:2000-2007; discussion 2007-2008 
8. Stolz D, Christ-Crain M, Morgenthaler N, Miedinger D, Leuppi J, Müller 
C, Bingisser R, Struck J, Müller B, Tamm M 2008 Plasma pro-
adrenomedullin but not plasma pro-endothelin predicts survival in 
exacerbations of COPD. Chest 134:263-272 
9. COPP D, CHENEY B 1962 Calcitonin-a hormone from the parathyroid 
which lowers the calcium-level of the blood. Nature 193:381-382 
10. HIRSCH P, GAUTHIER G, MUNSON P 1963 THYROID 
HYPOCALCEMIC PRINCIPLE AND RECURRENT LARYNGEAL 
NERVE INJURY AS FACTORS AFFECTING THE RESPONSE TO 
PARATHYROIDECTOMY IN RATS. Endocrinology 73:244-252 
11. COPP D, CAMERON E, CHENEY B, DAVIDSON A, HENZE K 1962 
Evidence for calcitonin--a new hormone from the parathyroid that lowers 
blood calcium. Endocrinology 70:638-649 
12. Pellegriti G, Leboulleux S, Baudin E, Bellon N, Scollo C, Travagli J, 
Schlumberger M 2003 Long-term outcome of medullary thyroid carcinoma 
in patients with normal postoperative medical imaging. Br J Cancer 88:1537-
1542 
13. Müller B, Becker K 2001 Procalcitonin: how a hormone became a marker 
and mediator of sepsis. Swiss Med Wkly 131:595-602 
14. Snider RJ, Nylen E, Becker K 1997 Procalcitonin and its component 
peptides in systemic inflammation: immunochemical characterization. J 
Investig Med 45:552-560 
References 
_____________________________________________________________________ 
 82 
15. Rosenfeld M, Amara S, Roos B, Ong E, Evans R 1981 Altered expression 
of the calcitonin gene associated with RNA polymorphism. Nature 290:63-65 
16. Beglinger C, Born W, Münch R, Kurtz A, Gutzwiller J, Jäger K, Fischer 
J Distinct hemodynamic and gastric effects of human CGRP I and II in man. 
Peptides 12:1347-1351 
17. Wimalawansa S 1997 Amylin, calcitonin gene-related peptide, calcitonin, and 
adrenomedullin: a peptide superfamily. Crit Rev Neurobiol 11:167-239 
18. Nuki C, Kawasaki H, Kitamura K, Takenaga M, Kangawa K, Eto T, 
Wada A 1993 Vasodilator effect of adrenomedullin and calcitonin gene-
related peptide receptors in rat mesenteric vascular beds. Biochem Biophys 
Res Commun 196:245-251 
19. Marutsuka K, Nawa Y, Asada Y, Hara S, Kitamura K, Eto T, Sumiyoshi 
A 2001 Adrenomedullin and proadrenomudullin N-terminal 20 peptide 
(PAMP) are present in human colonic epithelia and exert an antimicrobial 
effect. Exp Physiol 86:543-545 
20. Pio R, Martinez A, Unsworth E, Kowalak J, Bengoechea J, Zipfel P, 
Elsasser T, Cuttitta F 2001 Complement factor H is a serum-binding protein 
for adrenomedullin, and the resulting complex modulates the bioactivities of 
both partners. J Biol Chem 276:12292-12300 
21. Bone R, Balk R, Cerra F, Dellinger R, Fein A, Knaus W, Schein R, 
Sibbald W 1992 Definitions for sepsis and organ failure and guidelines for the 
use of innovative therapies in sepsis. The ACCP/SCCM Consensus 
Conference Committee. American College of Chest Physicians/Society of 
Critical Care Medicine. Chest 101:1644-1655 
22. Bone R, Sibbald W, Sprung C 1992 The ACCP-SCCM consensus 
conference on sepsis and organ failure. Chest 101:1481-1483 
23. Müller B, White J, Nylén E, Snider R, Becker K, Habener J 2001 
Ubiquitous expression of the calcitonin-i gene in multiple tissues in response 
to sepsis. J Clin Endocrinol Metab 86:396-404 
24. Domenech V, Nylen E, White J, Snider R, Becker K, Landmann R, 
Müller B 2001 Calcitonin gene-related peptide expression in sepsis: 
postulation of microbial infection-specific response elements within the 
calcitonin I gene promoter. J Investig Med 49:514-521 
25. Becker K, Nylén E, Snider R, Müller B, White J 2003 
Immunoneutralization of procalcitonin as therapy of sepsis. J Endotoxin Res 
9:367-374 
26. Morgenthaler N, Struck J, Chancerelle Y, Weglöhner W, Agay D, Bohuon 
C, Suarez-Domenech V, Bergmann A, Müller B 2003 Production of 
procalcitonin (PCT) in non-thyroidal tissue after LPS injection. Horm Metab 
Res 35:290-295 
27. Linscheid P, Seboek D, Nylen ES, Langer I, Schlatter M, Becker KL, 
Keller U, Muller B 2003 In vitro and in vivo calcitonin I gene expression in 
parenchymal cells: a novel product of human adipose tissue. Endocrinology 
144:5578-5584 
28. Linscheid P, Seboek D, Zulewski H, Keller U, Müller B 2005 
Autocrine/paracrine role of inflammation-mediated calcitonin gene-related 
peptide and adrenomedullin expression in human adipose tissue. 
Endocrinology 146:2699-2708 
29. Linscheid P, Seboek D, Schaer D, Zulewski H, Keller U, Müller B 2004 
Expression and secretion of procalcitonin and calcitonin gene-related peptide 
References 
_____________________________________________________________________ 
 83 
by adherent monocytes and by macrophage-activated adipocytes. Crit Care 
Med 32:1715-1721 
30. Muller B, Becker KL, Becker KL, Schachinger H, Rickenbacher PR, 
Huber PR, Zimmerli W, Ritz R 2000 Calcitonin precursors are reliable 
markers of sepsis in a medical intensive care unit. Crit Care Med 28:977-983 
31. Dandona P, Nix D, Wilson M, Aljada A, Love J, Assicot M, Bohuon C 
1994 Procalcitonin increase after endotoxin injection in normal subjects. J Clin 
Endocrinol Metab 79:1605-1608 
32. Simon L, Gauvin F, Amre D, Saint-Louis P, Lacroix J 2004 Serum 
procalcitonin and C-reactive protein levels as markers of bacterial infection: a 
systematic review and meta-analysis. Clin Infect Dis 39:206-217 
33. Harbarth S, Holeckova K, Froidevaux C, Pittet D, Ricou B, Grau G, 
Vadas L, Pugin J 2001 Diagnostic value of procalcitonin, interleukin-6, and 
interleukin-8 in critically ill patients admitted with suspected sepsis. Am J 
Respir Crit Care Med 164:396-402 
34. Schuetz P, Albrich W, Christ-Crain M, Chastre J, Mueller B 2010 
Procalcitonin for guidance of antibiotic therapy. Expert Rev Anti Infect Ther 
8:575-587 
35. Nylen E, Whang K, Snider RJ, Steinwald P, White J, Becker K 1998 
Mortality is increased by procalcitonin and decreased by an antiserum reactive 
to procalcitonin in experimental sepsis. Crit Care Med 26:1001-1006 
36. Steinwald P, Whang K, Becker K, Snider R, Nylen E, White J 1999 
Elevated calcitonin precursor levels are related to mortality in an animal model 
of sepsis. Crit Care 3:11-16 
37. Martinez J, Wagner K, Snider R, Nylen E, Muller B, Sarani B, Becker K, 
White J 2001 Late immunoneutralization of procalcitonin arrests the 
progression of lethal porcine sepsis. Surg Infect (Larchmt) 2:193-202; 
discussion 202-193 
38. Wagner K, Martinez J, Vath S, Snider R, Nylén E, Becker K, Müller B, 
White J 2002 Early immunoneutralization of calcitonin precursors attenuates 
the adverse physiologic response to sepsis in pigs. Crit Care Med 30:2313-
2321 
39. Sexton P, Christopoulos G, Christopoulos A, Nylen E, Snider RJ, Becker 
K 2008 Procalcitonin has bioactivity at calcitonin receptor family complexes: 
potential mediator implications in sepsis. Crit Care Med 36:1637-1640 
40. Becker K, Nylén E, White J, Müller B, Snider RJ 2004 Clinical review 167: 
Procalcitonin and the calcitonin gene family of peptides in inflammation, 
infection, and sepsis: a journey from calcitonin back to its precursors. J Clin 
Endocrinol Metab 89:1512-1525 
41. Joyce C, Fiscus R, Wang X, Dries D, Morris R, Prinz R 1990 Calcitonin 
gene-related peptide levels are elevated in patients with sepsis. Surgery 
108:1097-1101 
42. Hirata Y, Mitaka C, Sato K, Nagura T, Tsunoda Y, Amaha K, Marumo F 
1996 Increased circulating adrenomedullin, a novel vasodilatory peptide, in 
sepsis. J Clin Endocrinol Metab 81:1449-1453 
43. Struck J, Tao C, Morgenthaler N, Bergmann A 2004 Identification of an 
Adrenomedullin precursor fragment in plasma of sepsis patients. Peptides 
25:1369-1372 
References 
_____________________________________________________________________ 
 84 
44. Eto T 2001 A review of the biological properties and clinical implications of 
adrenomedullin and proadrenomedullin N-terminal 20 peptide (PAMP), 
hypotensive and vasodilating peptides. Peptides 22:1693-1711 
45. Christ-Crain M, Morgenthaler NG, Stolz D, Muller C, Bingisser R, 
Harbarth S, Tamm M, Struck J, Bergmann A, Muller B 2006 Pro-
adrenomedullin to predict severity and outcome in community-acquired 
pneumonia [ISRCTN04176397]. Crit Care 10:R96 
46. Christ-Crain M, Müller B 2008 Calcitonin peptides--the mediators in sepsis 
or just another fairy tale? Crit Care Med 36:1684-1687 
47. Linscheid P, Seboek D, Nylen E, Langer I, Schlatter M, Becker K, Keller 
U, Müller B 2003 In vitro and in vivo calcitonin I gene expression in 
parenchymal cells: a novel product of human adipose tissue. Endocrinology 
144:5578-5584 
48. Berg A, Scherer P 2005 Adipose tissue, inflammation, and cardiovascular 
disease. Circ Res 96:939-949 
49. Schäffler A, Schölmerich J, Salzberger B 2007 Adipose tissue as an 
immunological organ: Toll-like receptors, C1q/TNFs and CTRPs. Trends 
Immunol 28:393-399 
50. Charrière G, Cousin B, Arnaud E, André M, Bacou F, Penicaud L, 
Casteilla L 2003 Preadipocyte conversion to macrophage. Evidence of 
plasticity. J Biol Chem 278:9850-9855 
51. Kershaw E, Flier J 2004 Adipose tissue as an endocrine organ. J Clin 
Endocrinol Metab 89:2548-2556 
52. Ronti T, Lupattelli G, Mannarino E 2006 The endocrine function of adipose 
tissue: an update. Clin Endocrinol (Oxf) 64:355-365 
53. Takeda K, Akira S 2001 Regulation of innate immune responses by Toll-like 
receptors. Jpn J Infect Dis 54:209-219 
54. Visintin A, Mazzoni A, Spitzer J, Wyllie D, Dower S, Segal D 2001 
Regulation of Toll-like receptors in human monocytes and dendritic cells. J 
Immunol 166:249-255 
55. Dong Z, Yang Z, Wang C 2005 Expression of TLR2 and TLR4 messenger 
RNA in the epithelial cells of the nasal airway. Am J Rhinol 19:236-239 
56. Pivarcsi A, Kemény L, Dobozy A 2004 Innate immune functions of the 
keratinocytes. A review. Acta Microbiol Immunol Hung 51:303-310 
57. Bès-Houtmann S, Roche R, Hoareau L, Gonthier M, Festy F, Caillens H, 
Gasque P, Lefebvre d'Hellencourt C, Cesari M 2007 Presence of functional 
TLR2 and TLR4 on human adipocytes. Histochem Cell Biol 127:131-137 
58. Armant M, Fenton M 2002 Toll-like receptors: a family of pattern-
recognition receptors in mammals. Genome Biol 3:REVIEWS3011 
59. Kern P, Saghizadeh M, Ong J, Bosch R, Deem R, Simsolo R 1995 The 
expression of tumor necrosis factor in human adipose tissue. Regulation by 
obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest 
95:2111-2119 
60. Montague C, Prins J, Sanders L, Zhang J, Sewter C, Digby J, Byrne C, 
O'Rahilly S 1998 Depot-related gene expression in human subcutaneous and 
omental adipocytes. Diabetes 47:1384-1391 
61. Hoch M, Eberle A, Peterli R, Peters T, Seboek D, Keller U, Muller B, 
Linscheid P 2008 LPS induces interleukin-6 and interleukin-8 but not tumor 
necrosis factor-alpha in human adipocytes. Cytokine 41:29-37 
References 
_____________________________________________________________________ 
 85 
62. Taylor B, Sibbald W, Edmonds M, Holliday R, Williams C 1978 Ionized 
hypocalcemia in critically ill patients with sepsis. Can J Surg 21:429-433 
63. Zivin J, Gooley T, Zager R, Ryan M 2001 Hypocalcemia: a pervasive 
metabolic abnormality in the critically ill. Am J Kidney Dis 37:689-698 
64. Müller B, Becker K, Kränzlin M, Schächinger H, Huber P, Nylèn E, 
Snider R, White J, Schmidt-Gayk H, Zimmerli W, Ritz R 2000 Disordered 
calcium homeostasis of sepsis: association with calcitonin precursors. Eur J 
Clin Invest 30:823-831 
65. Song S, Karl I, Ackerman J, Hotchkiss R 1993 Increased intracellular Ca2+: 
a critical link in the pathophysiology of sepsis? Proc Natl Acad Sci U S A 
90:3933-3937 
66. Bhattacharyya J, Thompson K, Sayeed M 1991 Calcium-dependent and 
calcium-independent protease activities in skeletal muscle during sepsis. Circ 
Shock 35:117-122 
67. Liu M, Kang G 1987 Liver glycogen metabolism in endotoxin shock. II. 
Endotoxin administration increases glycogen phosphorylase activities in dog 
livers. Biochem Med Metab Biol 37:73-80 
68. Zaloga G, Washburn D, Black K, Prielipp R 1993 Human sepsis increases 
lymphocyte intracellular calcium. Crit Care Med 21:196-202 
69. Copp D 1970 Calcitonin and calcium metabolism. Can Med Assoc J 103:821-
824 
70. Syntichaki P, Tavernarakis N 2003 The biochemistry of neuronal necrosis: 
rogue biology? Nat Rev Neurosci 4:672-684 
71. Friedman J, Raisz L 1965 Thyrocalcitonin: inhibitor of bone resorption in 
tissue culture. Science 150:1465-1467 
72. Raisz L, Au W, Friedman J, Niemann I 1967 Thyrocalcitonin and bone 
resorption. Studies employing a tissue culture bioassay. Am J Med 43:684-690 
73. Warshawsky H, Goltzman D, Rouleau M, Bergeron J 1980 Direct in vivo 
demonstration by radioautography of specific binding sites for calcitonin in 
skeletal and renal tissues of the rat. J Cell Biol 85:682-694 
74. Canaff L, Zhou X, Hendy G 2008 The proinflammatory cytokine, 
interleukin-6, up-regulates calcium-sensing receptor gene transcription via 
Stat1/3 and Sp1/3. J Biol Chem 283:13586-13600 
75. Hendy G, D'Souza-Li L, Yang B, Canaff L, Cole D 2000 Mutations of the 
calcium-sensing receptor (CASR) in familial hypocalciuric hypercalcemia, 
neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia. 
Hum Mutat 16:281-296 
76. Coburn J, Elangovan L, Goodman W, Frazaõ J 1999 Calcium-sensing 
receptor and calcimimetic agents. Kidney Int Suppl 73:S52-58 
77. Hirsch P, Lester G, Talmage R 2001 Calcitonin, an enigmatic hormone: 
does it have a function? J Musculoskelet Neuronal Interact 1:299-305 
78. AM P 1993 Calcium homeostasis. In. In: Mundy GR, Martin TJ (eds) 
Physiology and Pharmacology of bone; Handbook Exp Pharm 107: Springer-
Verlag, Berlin; 1-65 
79. See A, Soo K 1997 Hypocalcaemia following thyroidectomy for 
thyrotoxicosis. Br J Surg 84:95-97 
80. Bihan H, Becker K, Snider R, Nylen E, Vittaz L, Lauret C, Modigliani E, 
Moretti J, Cohen R 2003 Calcitonin precursor levels in human medullary 
thyroid carcinoma. Thyroid 13:819-822 
References 
_____________________________________________________________________ 
 86 
81. Walter M, Meier C, Radimerski T, Iten F, Kränzlin M, Müller-Brand J, 
de Groot J, Kema I, Links T, Müller B 2010 Procalcitonin levels predict 
clinical course and progression-free survival in patients with medullary thyroid 
cancer. Cancer 116:31-40 
82. Carrión A, Link W, Ledo F, Mellström B, Naranjo J 1999 DREAM is a 
Ca2+-regulated transcriptional repressor. Nature 398:80-84 
83. Matsuda M, Yamamoto T, Hirata M 2006 Ca2+-dependent regulation of 
calcitonin gene expression by the transcriptional repressor DREAM. 
Endocrinology 147:4608-4617 
84. Ledo F, Carrión A, Link W, Mellström B, Naranjo J 2000 DREAM-
alphaCREM interaction via leucine-charged domains derepresses downstream 
regulatory element-dependent transcription. Mol Cell Biol 20:9120-9126 
85. Fischer J, Born W 1985 Novel peptides from the calcitonin gene: expression, 
receptors and biological function. Peptides 6 Suppl 3:265-271 
86. Poston G, Seitz P, Townsend CJ, Alexander R, Rajaraman S, Cooper C, 
Thompson J 1987 Calcitonin gene-related peptide: possible tumor marker for 
medullary thyroid cancer. Surgery 102:1049-1054 
87. Hvarfner A, Bergström R, Mörlin C, Theodorsson E, Ljunghall S 1988 
The calcitonin gene-related peptide (CGRP) response to intravenous calcium 
is related to blood pressure. Acta Physiol Scand 132:439-440 
88. Cooper C, Borosky S, Peng T 1985 Secretion of calcitonin gene-related 
peptide from baby rat thyroid glands in vitro. Proc Soc Exp Biol Med 
180:562-566 
89. Grunditz T, Ekman R, Håkanson R, Rerup C, Sundler F, Uddman R 
1986 Calcitonin gene-related peptide in thyroid nerve fibers and C cells: 
effects on thyroid hormone secretion and response to hypercalcemia. 
Endocrinology 119:2313-2324 
90. Ahrén B, Ekman R, Laurberg P 1989 Calcium stimulates the release of 
calcitonin gene-related peptide from the canine thyroid. Am J Physiol 
256:E597-599 
91. Morara S, Wang L, Filippov V, Dickerson I, Grohovaz F, Provini L, 
Kettenmann H 2008 Calcitonin gene-related peptide (CGRP) triggers Ca2+ 
responses in cultured astrocytes and in Bergmann glial cells from cerebellar 
slices. Eur J Neurosci 28:2213-2220 
92. Houchi H, Yoshizumi M, Shono M, Ishimura Y, Ohuchi T, Oka M 1996 
Adrenomedullin stimulates calcium efflux from adrenal chromaffin cells in 
culture: possible involvement of an Na+/Ca2+ exchange mechanism. Life Sci 
58:PL 35-40 
93. Shimekake Y, Nagata K, Ohta S, Kambayashi Y, Teraoka H, Kitamura 
K, Eto T, Kangawa K, Matsuo H 1995 Adrenomedullin stimulates two 
signal transduction pathways, cAMP accumulation and Ca2+ mobilization, in 
bovine aortic endothelial cells. J Biol Chem 270:4412-4417 
94. Uezono Y, Shibuya I, Ueda Y, Tanaka K, Oishi Y, Yanagihara N, Ueno S, 
Toyohira Y, Nakamura T, Yamashita H, Izumi F 1998 Adrenomedullin 
increases intracellular Ca2+ and inositol 1,4,5-trisphosphate in human 
oligodendroglial cell line KG-1C. Brain Res 786:230-234 
95. Ji S, Xue J, Wang C, Su S, He R 2005 Adrenomedullin reduces intracellular 
calcium concentration in cultured hippocampal neurons. Sheng Li Xue Bao 
57:340-345 
References 
_____________________________________________________________________ 
 87 
96. Huang W, Wang L, Yuan M, Ma J, Hui Y 2004 Adrenomedullin affects 
two signal transduction pathways and the migration in retinal pigment 
epithelial cells. Invest Ophthalmol Vis Sci 45:1507-1513 
97. Willoughby D, Cooper D 2007 Organization and Ca2+ regulation of adenylyl 
cyclases in cAMP microdomains. Physiol Rev 87:965-1010 
98. Serazin-Leroy V, Morot M, de Mazancourt P, Giudicelli Y 2001 
Differences in type II, IV, V and VI adenylyl cyclase isoform expression 
between rat preadipocytes and adipocytes. Biochim Biophys Acta 1550:37-51 
99. Nemecek G 1978 Stimulation of hamster adipocyte cyclic 3':5'-nucleotide 
phosphodiesterase activity by ionophore A23187 and calcium. J Cyclic 
Nucleotide Res 4:299-309 
100. de Bustros A, Ball D, Peters R, Compton D, Nelkin B 1992 Regulation of 
human calcitonin gene transcription by cyclic AMP. Biochem Biophys Res 
Commun 189:1157-1164 
101. Sassone-Corsi P 1995 Transcription factors responsive to cAMP. Annu Rev 
Cell Dev Biol 11:355-377 
102. Carrión A, Mellström B, Naranjo J 1998 Protein kinase A-dependent 
derepression of the human prodynorphin gene via differential binding to an 
intragenic silencer element. Mol Cell Biol 18:6921-6929 
103. Ledo F, Kremer L, Mellström B, Naranjo J 2002 Ca2+-dependent block of 
CREB-CBP transcription by repressor DREAM. EMBO J 21:4583-4592 
104. Ardaillou R 1975 Kidney and calcitonin. Nephron 15:250-260 
105. Marx S, Woodward C, Aurbach G 1972 Calcitonin receptors of kidney and 
bone. Science 178:999-1001 
106. Moran J, Hunziker W, Fischer J 1978 Calcitonin and calcium ionophores: 
cyclic AMP responses in cells of a human lymphoid line. Proc Natl Acad Sci 
U S A 75:3984-3988 
107. Poyner D, Andrew D, Brown D, Bose C, Hanley M 1992 Pharmacological 
characterization of a receptor for calcitonin gene-related peptide on rat, L6 
myocytes. Br J Pharmacol 105:441-447 
108. Van Valen F, Piechot G, Jürgens H 1990 Calcitonin gene-related peptide 
(CGRP) receptors are linked to cyclic adenosine monophosphate production in 
SK-N-MC human neuroblastoma cells. Neurosci Lett 119:195-198 
109. Zaidi M, Datta H, Bevis P 1990 Kidney: a target organ for calcitonin gene-
related peptide. Exp Physiol 75:27-32 
110. Uezono Y, Nakamura E, Ueda Y, Shibuya I, Ueta Y, Yokoo H, Yanagita 
T, Toyohira Y, Kobayashi H, Yanagihara N, Wada A 2001 Production of 
cAMP by adrenomedullin in human oligodendroglial cell line KG1C: 
comparison with calcitonin gene-related peptide and amylin. Brain Res Mol 
Brain Res 97:59-69 
111. Ishizaka Y, Tanaka M, Kitamura K, Kangawa K, Minamino N, Matsuo 
H, Eto T 1994 Adrenomedullin stimulates cyclic AMP formation in rat 
vascular smooth muscle cells. Biochem Biophys Res Commun 200:642-646 
112. Yousufzai S, Ali N, Abdel-Latif A 1999 Effects of adrenomedullin on cyclic 
AMP formation and on relaxation in iris sphincter smooth muscle. Invest 
Ophthalmol Vis Sci 40:3245-3253 
113. Eguchi S, Hirata Y, Kano H, Sato K, Watanabe Y, Watanabe T, 
Nakajima K, Sakakibara S, Marumo F 1994 Specific receptors for 
adrenomedullin in cultured rat vascular smooth muscle cells. FEBS Lett 
340:226-230 
References 
_____________________________________________________________________ 
 88 
114. deBustros A, Baylin S, Levine M, Nelkin B 1986 Cyclic AMP and phorbol 
esters separately induce growth inhibition, calcitonin secretion, and calcitonin 
gene transcription in cultured human medullary thyroid carcinoma. J Biol 
Chem 261:8036-8041 
115. Spiegelman B, Farmer S 1982 Decreases in tubulin and actin gene 
expression prior to morphological differentiation of 3T3 adipocytes. Cell 
29:53-60 
116. Galley H, Webster N 1996 The immuno-inflammatory cascade. Br J Anaesth 
77:11-16 
117. Chung S, Lapoint K, Martinez K, Kennedy A, Boysen Sandberg M, 
McIntosh M 2006 Preadipocytes mediate lipopolysaccharide-induced 
inflammation and insulin resistance in primary cultures of newly differentiated 
human adipocytes. Endocrinology 147:5340-5351 
118. Fain J, Madan A, Hiler M, Cheema P, Bahouth S 2004 Comparison of the 
release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes 
from visceral and subcutaneous abdominal adipose tissues of obese humans. 
Endocrinology 145:2273-2282 
119. Wellen K, Hotamisligil G 2005 Inflammation, stress, and diabetes. J Clin 
Invest 115:1111-1119 
120. Ammori B, Becker K, Kite P, Snider R, Nylén E, White J, Larvin M, 
McMahon M 2003 Calcitonin precursors in the prediction of severity of acute 
pancreatitis on the day of admission. Br J Surg 90:197-204 
121. Vitseva O, Tanriverdi K, Tchkonia T, Kirkland J, McDonnell M, Apovian 
C, Freedman J, Gokce N 2008 Inducible Toll-like receptor and NF-kappaB 
regulatory pathway expression in human adipose tissue. Obesity (Silver 
Spring) 16:932-937 
122. Andreakos E, Sacre S, Smith C, Lundberg A, Kiriakidis S, Stonehouse T, 
Monaco C, Feldmann M, Foxwell B 2004 Distinct pathways of LPS-induced 
NF-kappa B activation and cytokine production in human myeloid and 
nonmyeloid cells defined by selective utilization of MyD88 and Mal/TIRAP. 
Blood 103:2229-2237 
123. Sacre S, Andreakos E, Feldmann M, Foxwell B 2004 Endotoxin signaling 
in human macrophages: signaling via an alternate mechanism. J Endotoxin 
Res 10:445-452 
124. Zhong W, Burke P, Hand A, Walsh M, Hughes L, Forse R 1993 
Regulation of cytokine mRNA expression in lipopolysaccharide-stimulated 
human macrophages. Arch Surg 128:158-163; discussion 163-154 
125. Xia Y, Feng L, Yoshimura T, Wilson C 1993 LPS-induced MCP-1, IL-1 
beta, and TNF-alpha mRNA expression in isolated erythrocyte-perfused rat 
kidney. Am J Physiol 264:F774-780 
126. Rodeberg D, Babcock G 1996 Role of calcium during lipopolysaccharide 
stimulation of neutrophils. Infect Immun 64:2812-2816 
127. Prpic V, Weiel J, Somers S, DiGuiseppi J, Gonias S, Pizzo S, Hamilton T, 
Herman B, Adams D 1987 Effects of bacterial lipopolysaccharide on the 
hydrolysis of phosphatidylinositol-4,5-bisphosphate in murine peritoneal 
macrophages. J Immunol 139:526-533 
128. Letari O, Nicosia S, Chiavaroli C, Vacher P, Schlegel W 1991 Activation 
by bacterial lipopolysaccharide causes changes in the cytosolic free calcium 
concentration in single peritoneal macrophages. J Immunol 147:980-983 
References 
_____________________________________________________________________ 
 89 
129. Ohmori Y, Hamilton T 1992 Ca2+ and calmodulin selectively regulate 
lipopolysaccharide-inducible cytokine mRNA expression in murine peritoneal 
macrophages. J Immunol 148:538-545 
130. Hotchkiss R, Osborne D, Lappas G, Karl I 1995 Calcium antagonists 
decrease plasma and tissue concentrations of tumor necrosis factor-alpha, 
interleukin-1 beta, and interleukin-1 alpha in a mouse model of endotoxin. 
Shock 3:337-342 
131. Lo C, Garcia I, Cryer H, Maier R 1996 Calcium and calmodulin regulate 
lipopolysaccharide-induced alveolar macrophage production of tumor necrosis 
factor and procoagulant activity. Arch Surg 131:44-50 
132. West M, Clair L, Bellingham J 1996 Role of calcium in lipopolysaccharide-
stimulated tumor necrosis factor and interleukin-1 signal transduction in naive 
and endotoxin-tolerant murine macrophages. J Trauma 41:647-652 
133. Weigert C, Düfer M, Simon P, Debre E, Runge H, Brodbeck K, Häring H, 
Schleicher E 2007 Upregulation of IL-6 mRNA by IL-6 in skeletal muscle 
cells: role of IL-6 mRNA stabilization and Ca2+-dependent mechanisms. Am 
J Physiol Cell Physiol 293:C1139-1147 
134. Freichel M, Zink-Lorenz A, Holloschi A, Hafner M, Flockerzi V, Raue F 
1996 Expression of a calcium-sensing receptor in a human medullary thyroid 
carcinoma cell line and its contribution to calcitonin secretion. Endocrinology 
137:3842-3848 
135. Bouschet T, Henley J 2005 Calcium as an extracellular signalling molecule: 
perspectives on the Calcium Sensing Receptor in the brain. C R Biol 328:691-
700 
136. Ikura M, Osawa M, Ames J 2002 The role of calcium-binding proteins in the 
control of transcription: structure to function. Bioessays 24:625-636 
137. Matsuda M, Yamamoto TA, Hirata M 2006 Ca2+-dependent regulation of 
calcitonin gene expression by the transcriptional repressor DREAM. 
Endocrinology 147:4608-4617 
138. Hotchkiss R, Karl I 1994 Dantrolene ameliorates the metabolic hallmarks of 
sepsis in rats and improves survival in a mouse model of endotoxemia. Proc 
Natl Acad Sci U S A 91:3039-3043 
139. Sirmagul B, Kilic F, Tunc O, Yildirim E, Erol K 2006 Effects of verapamil 
and nifedipine on different parameters in lipopolysaccharide-induced septic 
shock. Heart Vessels 21:162-168 
140. Cameron E, Zhuang J, Menconi M, Phipps R, Fink M 1996 Dantrolene, an 
inhibitor of intracellular calcium release, fails to increase survival in a rat 
model of intra-abdominal sepsis. Crit Care Med 24:1537-1542 
141. Christ-Crain M, Morgenthaler N, Stolz D, Müller C, Bingisser R, 
Harbarth S, Tamm M, Struck J, Bergmann A, Müller B 2006 Pro-
adrenomedullin to predict severity and outcome in community-acquired 
pneumonia [ISRCTN04176397]. Crit Care 10:R96 
142. Bernstein R, Hyun W, Davis J, Fulwyler M, Pershadsingh H 1989 Flow 
cytometric analysis of mature adipocytes. Cytometry 10:469-474 
143. Beer S, Weighardt H, Emmanuilidis K, Harzenetter M, Matevossian E, 
Heidecke C, Bartels H, Siewert J, Holzmann B 2002 Systemic neuropeptide 
levels as predictive indicators for lethal outcome in patients with postoperative 
sepsis. Crit Care Med 30:1794-1798 
References 
_____________________________________________________________________ 
 90 
144. Arnalich F, Sánchez J, Martínez M, Jiménez M, López J, Vázquez J, 
Hernanz A 1995 Changes in plasma concentrations of vasoactive 
neuropeptides in patients with sepsis and septic shock. Life Sci 56:75-81 
145. Hahn P, Yoo P, Ba Z, Chaudry I, Wang P 1998 Upregulation of Kupffer 
cell beta-adrenoceptors and cAMP levels during the late stage of sepsis. 
Biochim Biophys Acta 1404:377-384 
 
 
Acknowledgements 
_____________________________________________________________________ 
 91 
8. Acknowledgments 
 
First of all, I want to thank my supervisor Prof. Beat Müller for the opportunity to 
perform my PhD thesis in his lab. I feel deeply grateful for all the freedom and 
reliance he gave me during my years as a PhD student and especially for supporting 
my work-life balance after the birth of my child.  
 
Furthermore, I want to thank Prof. Alex Eberle and Prof. Karl Hofbauer for refereeing 
my PhD thesis and Prof. Jean Pieters for leading the oral exam. 
 
I also thank PD Henryk Zulewski, Prof. Mirjam Christ-Crain and Prof. Ulrich Keller 
for all their kind support, helpful inputs and interesting discussions. 
 
I am grateful to Dr. Martin Walter for letting me participate in his interesting and 
successful studies on MTC. 
 
I would like to address my thankfulness to Kaethi Dembinski for invaluable technical 
support and advices. Without her help this work could not have been realized. 
Additionally her jolly nature and all the nice and funny discussions during lunch and 
coffee breaks even made the hard working days pleasant. 
 
I deeply appreciated to have Dr. Jean Grisouard as a colleague and want to thank him 
for supporting me with priceless advises and critical scientific inputs to my project. I 
could always benefit of his experience in the scientific field. Additionally his positive 
attitude and happiness always cheered me up. 
 
Many thanks go to Dr. Katharina Timper. It was a great and enjoyable experience to 
work together with her in a lab. Her very kind and inspiring characteristics helped me 
to motivate myself in busy times even when everything seemed to go wrong. 
 
Thanks as well to the former members of the lab Jürg Lerch, Marco Fischer, Elisa 
Bouillet, Constanze Baranek, Dr. Philippe Linscheid, to our nice lab neighbors 
Acknowledgements 
_____________________________________________________________________ 
 92 
Stephanie Häuselmann, Vera Lorenz and Berit Rosc and to all the other friendly and 
kind people from the DBM. Especially I would like to thank Dr. Dalma Seboek Kinter 
for her invaluable friendship and for all her help and support concerning my thesis. 
 
I am grateful to Dr. Daniel Frey and Dr. Ralph Peterli for providing us with fat tissue 
samples. 
 
I appreciated a lot the great help from Beat Erne with the calcium measurements and 
confocal microscopy. Many thanks also to Vreni Jäggin and Emmanuel Traunecker 
for their help with flow cytometry. 
 
During my graduate studies I enjoyed the priceless support of my dear friends and my 
beloved family, making them the ones that should be appreciated most. Especially I 
would like to thank my father Dr. Paul Radimerski for helping with linguistic issues 
and Fredy Herzog for often taking care of Ivan enabling me to write on my thesis. The 
largest part of my affection goes to my future husband Christoph Herzog whom I 
want to thank for all his love and support and to my son Ivan whom I want to thank 
for all the joy and pleasure he is giving to my live. 
Curriculum vitae 
_____________________________________________________________________ 
 93 
9. Curriculum vitae 
 
name : Tanja Marianna Radimerski 
 
birth place/date: Basel, 18th of December  1976  
 
nationality : Swiss and Czech 
 
Family status : unmarried 
1 child 
   
 
Education: 
 
2006 - 2010 
 
PhD studies in medical-biological research 
University Hospital Basel, Switzerland 
Department of Biomedicine 
 
Supervision: Prof. Dr. Beat Müller 
 
Title: The regulation of calcitonin genes upon bacterial infection 
and sepsis in human adipocytes 
 
2002-2003 
 
 
Diploma thesis in neurobiology 
University of Basel, Switzerland 
Neurobiology 
 
Supervision: Prof. Dr. Heinrich Reichert 
 
Title: Genetic rescue of the ems mutant brain 
phenotype in Drosophila by Coral emx transgene expression 
 
1997-2003 University of Basel, Switzerland 
Faculty of science 
Biology 
 
 
Working experience: 
 
2003 - 2006 
 
Novartis Pharma AG 
Supply Chain  
Global Material Master Management 
Key Account Manager 
 
 
1997 - 2003 
 
Novartis International AG 
supervision of the Novartis Communication Shop 
 
 
 
Curriculum vitae 
_____________________________________________________________________ 
 94 
May 2003 
 
Sekundarschule Reinach: Substitute teacher for biology, 
geographics and mathematics 
 
2002 
 
Hilfsassistenz Uni Basel 
Orientierungs- Schule Basel: Substitute teacher for biology, 
geographic and mathematics 
Sekundarschule Reinach: Substitute teacher for biology and 
geographic 
 
 
Languages : 
 
German (mother language) 
English (orally and written)  
French and Czech (basic understanding) 
 
 
Computer  
skills : 
 
MS-Office (Outlook, Word, Excel, PowerPoint) 
EndNote, GraphPad Prism 
 
 
Further  
education :  
 
Höheres Lehramt Mittelschulen, Zürich, Switzerland  
(2 Semester 2005/2006) 
 
 
Publications :  
 
T.Radimerski, J. Grisouard, K. Timper, H. Zulewski, M. Christ-Crain, U. Keller, B. 
Müller (2010) 
Role of calcium in lipopolysaccharide-induced calcitonin gene expression in human 
adipocytes. Innate Immunity (in press) 
 
M. Fischer, K.Timper, T.Radimerski, K. Dembinski, D.M. Frey, H. Zulewski, U. 
Keller, B.Müller, M. Christ-Crain,J. Grisouard (2010) 
Metformin induces glucose uptake in human preadipocyte-derived adipocytes from 
various fat depots. Diabetes, Obesity and Metabolism 12: 356–359 
 
Walter MA, Meier C, Radimerski T, Iten F, Kränzlin M, Müller-Brand J, de Groot 
JW, Kema IP, Links TP, Müller B (2010) 
Procalcitonin levels predict clinical course and progression-free survival in patients 
with medullary thyroid cancer. Cancer Jan 1;116(1):31-40. 
 
Egger B, Leemans R, Loop T, Kammermeier L, Fan Y, Radimerski T, Strahm MC, 
Certa U, Reichert H (2002)  
Gliogenesis in Drosophila: Genome-wide analysis of downstream genes of glial cells 
missing in the embryonic nervous system. Development 129:3295-3309 
 
 
 
 
 
 
Appendix 
_____________________________________________________________________ 
 95 
10. Appendix 
 
Declaration 
 
I declare that I wrote this thesis ‘The regulation of calcitonin genes upon bacterial 
infection and sepsis in human adipocytes’ with the help indicated and only handed it 
in to the faculty of science of the University of Basel and to no other faculty and no 
other university. 
 
 
Basel, 2010 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix 
_____________________________________________________________________ 
 96 
Publication 
 
 
Accepted for publication in Innate Immunity 
 
 
 
Role of calcium in lipopolysaccharide-induced calcitonin gene 
expression in human adipocytes 
 
Running Title: LPS induced Ca2+ increase and CALC-gene expression  
 
Tanja M. Radimerski* 1, Jean Grisouard 1, Katharina Timper 1,2, Henryk Zulewski 1,2, 
Mirjam Christ-Crain 1,2, Ulrich Keller 1,2 and Beat Müller 1,3  
 
1
 Department of Biomedicine, University Hospital Basel, CH-4031 Basel, Switzerland 
2
 Division of Endocrinology, Diabetes and Clinical Nutrition, University Hospital 
Basel, CH-4031 Basel, Switzerland 
3
 Department of Internal Medicine, Kantonsspital Aarau, CH-5001 Aarau, 
Switzerland 
 
Key words: bacterial infection, CALC genes, calcium, human adipocytes, 
lipopolysaccharide, 
 
 
*Corresponding author:  
Mailing address: University Hospital Basel, Department of Biomedicine,  
Hebelstrasse, 20, 4031 Basel, Switzerland 
Phone.: +41 61 265 23 81 
Fax: +41 61 265 23 50 
e-mail: tanja.radimerski@unibas.ch 
 
 
